CURRICULUM VITAE

Name Prof. Dr. med. Jakob R. Passweg, M.S. Date 8/18/2015 born June 21, 1959, Biel-Bienne, Switzerland Family married to: Marianne Schnegg Passweg M.D. children Jonas Raphaël, born August 30th 1996 Lea Pauline, born January 20th 2000 Office Chefarzt Klinik für Hämatologie Bereich Innere Medizin Universitätsspital Basel Petersgraben 4 4031 Basel Phone / Fax ++4161-3287277/ ++4161-2654450 E-mail jpassweg@uhbs.ch Home Bättwilerstr 12 4054 Basel Phone ++4176-3827544 Social Sec 756.3805.3814.44 Education/ Diplomas 1978 Graduated High School (Matura), Dt. Gymnasium, Biel 1984 Graduated, Medical School, University of Berne, Switzerland 1987 Dissertation, University of Berne 1994 Swiss Board Certification (FMH) Internal Medicine and Hematology 1996 Master of Science, Epidemiology, Medical College of Wisconsin, USA Postgraduate Training 1985 Institute for Clinical Pharmacology, University of Berne, CH (Prof. R. Preisig, MD Thesis) 1985 Editorial assistant, pharma-kritik drug letter (Dr. E Gysling) 1986 Residency Internal Medicine, Ziegler City Hospital Berne (Prof. R Hoigné) 1987 Residency Geriatrics, Basel University Hospital (Prof. H.B.Stähelin) 1988 Residency Internal Medicine Kantonsspital Bruderholz (Prof. H.Kummer) 1990 Residency Internal Medicine Basel University Hospital (Prof. W. Stauffacher) 1991 Fellowship Nephrology, Basel University Hospital (Prof. G. Thiel) 1990 Fellowship Hematology, Basel Univ Hospital (Proff. B. Speck, A.Gratwohl, A. Tichelli) 1994 Clinical and Research Fellow, International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin (Prof. MM Horowitz) and Bone Marrow

1

Transplant Program MCW (Prof. W. Burns) Academic position 1995 Visiting Assistant Professor, Health Policy Institute, Medical College of Wisconsin, USA 2001 Venia docendi, University of Basel, Medizinische Fakultät, Innere Medizin 2005 Professeur ordinaire, Faculté de Médecine, Université de Genève 2011 Ordinarius Hämatologie, Medizinische Fakultät, Universität Basel Clinical Position 96-02 Attending physician (Oberarzt), Hematology Division; Basel University Hospital 02-05 Leitender Arzt, Hematology Division; Basel University Hospital 05-10 Chair, Hematology Division, Hôpitaux Universitaires de Genève Professor of Hematology, Geneva University Current Position 2011 Chair, Hematology Division, Basel University Hospital Professor of Hematology, Basel University Activities • Secretary of the Nordwestschweizer Arbeitsgemeinschaft Onkologie, 1997-2005 • Secretary of the Severe Aplastic Anemia Working Party of the European Bone Marrow

Transplant Group (EBMT) 1998-2004 • Scientific Advisor, STABMT (Swiss Transplant, Bone Marrow Transplant) Registry, 1998 • Data manager of the Autoimmune Disease Working Party of the EBMT, 1998-2004 • Chairman of the Allogeneic Minitransplant Group of the SAKK ((Schweizerische

Arbeitsgruppe Klinische Krebsforschung) (2001-2005) • Board member SAKK (2001-2005) • Executive Committee of the International Bone Marrow Transplant Registry, Member at

Large (2004-2006) • Advisory Committee of the Center for International Bone Marrow Transplant Research,

Member at Large (2006-07) • Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group

(EBMT, European Group for Blood and Marrow Transplantation), chairman (2004-10) • Komission unverwandte Knochenmarkstransplantation Swiss Blood Stem Cells 2005 • Chair Komission unverwandte Knochenmarkstransplantation Swiss Blood Stem Cells 2006-

2012 • STABMT (SwissTransplant, Arbeitsgruppe Bone Marrow Transplant), board member, 2006 • Société Suisse d’Hématologie, Board member, 2006; • Swisscord, Board member, 2006-2010; Chairman 2012 - • Swiss Cancer League ,Vice president, 2007-10 • Swiss Cancer League, President, 2010 • European Hematology Association: Fellowship and Grants Review Committee 2010 • Ad hoc Scientific Committee on Bone Marrow Failure, American Society of Hematology,

Member, 2011 • NICER (National Institute for Cancer Epidemiology and Research) Foundation Council,

Switzerland, Member 2010 • Steering Committee, Basel Stem Cell Network, 2011 • Swissbridge Foundation Council 2011

2

• Chair Swisscord 2012 • Treasurer, Swiss Society of Hematology 2012 • President, Swissbridge Foundation Council 2013 Grant Support • Basel Section of the Swiss Cancer League, Switzerland, 1994 • Swiss National Fund for Research, Switzerland, 1994 • Ciba-Geigy Jubilaeums Foundation, Basel Switzerland, 1994 • Free Academic Society, Basel Switzerland, 1994 • Cancer Center of the Medical College of Wisconsin, USA, 1996 • NFP 4046-058668 AB0-Incompatibility and Hyper-Acute Xenograft Rejection; 2000,

(Coinvestigator) • NFP 3200B0-106105/1 Hematopoetic Stem Cell Transplantation: Factors associated iwth ist

use and outcome, coinvestigator (CHF 227k) • Schweiz. Arbeitsgem. für Klinische Krebsforschung (SAKK) 2004 (CHF 20k) • Stiftung für Hämatologische Forschung, Basel 2004 (CHF 20k) • Jacques und Gloria Gossweiler Stiftung 2006 (CHF 100k) • Fondation Dr Henri Dubois-Ferrière - Dinu Lipatti (Co-investigator) (CHF 60k) • Krebsliga Schweiz 2009. KFS-02464-08-2009 Bertrand Huard: APRIL blockade for the

treatment of Multiple Myeloma? (Co-investigator) (CHF 320k) • Immunotherapy with NK cells: adoptive transfer of ex vivo expanded and activated NK cells

in elderly patients with acute myeloid leukemia Biology and medicine (division III) NFP: 32003B_149647. (Principal Investigator)

Membership • American Society of Hematology • American Society of Blood and Marrow Transplantation • European Hematology Association • European Group of Blood and Marrow Transplantation, EBMT • Deutsche Gesellschaft für Hämatologie und Onkologie • Swiss Society of Internal Medicine • Swiss Society of Hematology • Swiss Transplantation Society Meeting Organization • EBMT annual meeting 2002 Montreux, Switzerland, Scientific Secretary • DGHO/OeGHO/SGMO/SGH meeting 2003, Basel Switzerland, Scientific Secretary • EHA-9, 2004 Geneva (European Hematology Association annual meeting) Organizing

Commitee • ICHS 2006 (Immunocompromised host society) Montana, Switzerland, Organizing Commitee • 7th International Donor Registry Conference and WMDA Working Group Meeting (Berne,

Switzerland, 16 – 19 April 2008) National Scientific Committee • 14th annual training course of the Swiss Society of Hematology 2008 Geneva Congress

President • DGHO/OeGHO/SGMO/SGH meeting 2011, Basel Switzerland, Organizing Commitee • EBMT annual meeting 2012 Geneva Switzerland, Congress President

3

Editorial Position Co-Editor Bone Marrow Transplantation 2007 -> Conseil de Rédaction: Revue Médicale Suisse 2006 - 2010 Editorial Board, Hematologica, The Hematology Journal 2008 -> Associate Editor: Annals of Hematology 2009 -> Editorial Review American Journal of Hematology, American Journal of Nephrology, Annals of Hematology, Annals of Oncology, Anti-Cancer Drugs, Autoimmune Diseases, Archivum Immunologiae et Therapieae Experimentalis, Biology of Blood and Marrow Transplantation, BLOOD, Bone Marrow Transplantation, British Journal of Cancer, British Journal of Haematology, Cell Transplantation, Clinical Immunology, Clinical Infectious Diseases, Clinical Chemistry and Laboratory Medicine, Clinical and Developmental Immunology, Clinical Transplantation, Critical Reviews in Oncology/Hematology, Current Stem Cell Research & Therapy (CSCR), Cytotherapy, European Journal of Clinical Investigation, Experimental Hematology, Expert Opinion On Biological Therapy, Hematologica, Infection, Journal of Critical Care, Journal of Hematotherapy and Stem Cell Research, Journal of Pediatric Hematology/Oncology, Journal of Transplantation, Leukemia, Leukemia & Lymphoma, Neurology, Oncology, Onkologie, Pathobiology, Swiss Medical Weekly, The Hematology Journal, The International Journal of the Health Sciences Centre of Kuwait University, Transfusion and Apheresis Science, Transplant International, Transplant Infectious Disease, Vox Sanguinis Project Review SNF (Swiss National Science Foundation), Dutch Cancer Society, INCA (Institut National de Cancer) Awards 1991: poster prize Swiss Society of Nephrology 2009: best clinical research award: Swiss Society of Hematology Teaching (since 2006) Faculté de médecine, Université de Genève pregraduation students Travaux pratiques en hématologie (2/3ème année, unité défense et immunité) UIDC (4ème année) Unité d’Introduction à la démarche clinique:

- Forum Anémie (2h) - Forum Thrombocytopénie (1h) - AMC (4ème /5ème année, Apprentissage en milieu clinique) fatigue et anémie (10h)

Cours à choix (5ème année): enseigment module transplantation: Greffe de moelle (4h) Federal exams (6h) Basel University, Medical Faculty, Master (4th year): Themenblock Blut, Infekt, Abwehr (6h) Basel University, Medical Faculty, Bachelor (2nd year), From Symptom zur Diagnose Basel University,Phil II faculty, Stem Cell Biology, Graduate Programme

4

Original Publications 1. M.G. Bianchetti, R. Krämer, J. Passweg, J. Jost, R. Preisig: Use of Salivary Levels to Predict

Clearance of Caffeine in Patients with Cystic Fibrosis: J.Pediatr. Gastroenterol. Nutr. 1988; 7: 688

2. J. Passweg, U. Buser, A. Tichelli, A. Gratwohl, B. Speck: Pustular eruption at the site of

subcutaneous injection of human granulocyte-macrohpage colony-stimulating factor: Ann. Hematol.: 1991; 63: 326 IF: 1.416

3. J. Passweg, H.A. Bock, A. Tichelli, G. Thiel: ‘Transient multiple myeloma’ after intense

immunosuppression in a renal transplant patient. Nephrol. Dialys. Transplant. 1993; 8:1393-4 IF: 2.57

4. J. Passweg, A. Gratwohl, G. Stauffer, U. Buser, A. Tichelli, R. Herrmann, B.Speck, W.

Stauffacher: Die Isolierstation am Kantonsspital Basel, Erfahrungsbericht nach 4 Jahren: Schweiz. Med. Wschr. 1994; 124: 62-8 IF: 0.770

5. A. Gratwohl, A. Tichelli, G. Stauffer, J. Passweg, M. Pless, D. Gengenbacher, U. Buser, E.

Signer, C. Haberthür, C. Gimmi. Wie lange muss Cyclosporin nach einer Knochenmarkstransplantation verabreicht werden? Schweiz. Med. Wschr. 1994; 124: 44-50 IF: 0.770

6. KA. Sobocinski, MM. Horowitz, PA. Rowlings, M-J. Zhang, ML. Nugent JR. Passweg, JO.

Armitage, RP. Gale MM. Bortin: Bone Marrow Transplantation - 1994: A report from the International Bone Marrow Transplant Registry and the North Anerican Autologous Bone Marrow Transplant Registry. Journal of Hematotherapy 1994; 3: 95-102 IF: 1.628

7. M. Bargetzi, A. Schönenberger, A. Tichelli, C. Gimmi, J. Passweg, M. Rabaglio, D. Sagoli, G.

Sissolak, A. Gratwohl, B. Speck. Hydroxyurea, Erythrozytenvolumen und Hämoglobin F. Schweiz. Med. Wschr. 1995; 125: 433 IF: 0.770

8. M. Rabaglio, A. Tichelli, M. Tamm, M. Bargetzi, C. Gimmi, B. Orth, J. Passweg, A.

Schönenberger, G. Sissolak, A. Gratwohl, B. Speck. Späte idiopathische Pneumopathie nach Knochenmarks-transplantation. Schweiz. Med. Wschr. 1995; 125: 412 IF: 0.770

9. T. Egger, A. Gratwohl, A. Tichelli, M. Uhr, C. Stebler, J. Passweg, M. Pless, M. Wernli, U.

Buser, J. Wuhrmann, R. Frei, C. Nissen, B. Speck: Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. Support. Care Cancer 1995; 3: 139-146 IF: 1.299

10. MM Horowitz, PA Rowlings, JR Passweg. Allogeneic bone marrow transplantation for CML:

a report from the International Bone Marrow Transplant Registry. Bone Marrow Transplantation 1996; 17:(Suppl 3) S3-6 IF: 2.378

11. J. Passweg, G. Thiel, H.A. Bock. Monoclonal Gammopathy after Intense Induction

Immunosuppression in Renal Transplant Patients: Nephrol. Dialys. Transplant., 1996; 11: 2461-2465 IF: 2.57

5

12. JR Passweg, G Socié, W Hinterberger, A Bacigalupo, JC Biggs, BM Camitta, RE Champlin, RP Gale, E Gluckman, EC Gordon-Smith, JM Hows, JP Klein, ML Nugent, PA Rowlings, B Speck, A Tichelli, M-J Zhang, MM Horowitz, MM. Bortin. Bone Marrow Transplantation for Severe Aplastic Anemia: Has Outcome Improved? BLOOD 1997; 90: 858-864 IF: 9.631

13. Rowlings PA, Przepiorka D, Klein JP, Gale RP, Henslee-Downey PJ, Cahn J-Y, Calderwood

S, Gratwohl A, Socié G, Abecasis MM, Passweg JR, Sobocinski KA, Zhang M-J, Horowitz MM. IBMTR severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade British Journal of Hematology 1997; 97: 855-864 IF: 3.052

14. CA Keever-Taylor, J Passweg, Y Kawanishi, J Casper, N Flomenberg and LA Baxter-Lowe.

Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation Bone Marrow Transplantation 1997; 19: 1001 IF: 2.378

15. Y Kawanishi, J Passweg, WR Drobyski, P Rowlings, A Cook-Craig, J Casper, D Pietryga, F

Garbrecht, B Camitta, M Horowitz, M Juckett, D Margolis, N Flomenberg and CA Keever-Taylor. Effect of T-cell subset dose on outcome of T-cell depleted bone marrow transplantation. Bone Marrow Transplantation 1997; 19: 1069 IF: 2.378

16. Curtis RE, Rowlings PA, Deeg J, Shriner D, Socié G, Travis LB, Horowitz MM, Witherspoon

RP, Hoover RN, Sobocinski KA, Fraumeni JF, Boice JD, Schoch G, Travis WD, Sale GE, Kolb HJ, Passweg JR, Storb R, Gale RP. Solid cancers after bone marrow transplantation. New England Journal of Medicine 1997; 336: 897 IF: 31.736

17. Szomor A, Passweg J, Tichelli A, Hoffmann T, Speck B, Gratwohl A. Myeloid Leukemia and

Myelodysplastic Syndrome Relapsing as Granulocytic Sarcoma (Chloroma) after Allogeneic Bone Marrow Transplantation. Annals of Hematology 1997; 75: 239-41 IF: 1.416

18. JR Passweg, PA Rowlings, KA Atkinson, AJ Barrett, RP Gale, A Gratwohl, N Jacobsen, JP

Klein, P Ljungman, JA Russell, UW Schaefer, KA Sobocinski, JM Vossen, M-J Zhang, MM Horowitz. Influence of Protective Isolation on Outcome of Allogeneic Bone Marrow Transplantation for Leukemia. Bone Marrow Transplantation 1998; 21: 1231-1238 IF: 2.378

19. Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein

JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM. Survival with bone marrow transplantation versus hydroxyurea or interferon for chonic myelogenous leukemia (CML). BLOOD 1998; 91: 1810 IF: 9.631

20. Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings P, Sobocinski

KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM. Chemotherapy versus HLA-identical sibling transplants for adults with acute lymphoblastic leukemia in first remission. Bone Marrow Transplantation 1998; 22: 253 IF: 2.378

21. Tichelli A, Passweg J, Nissen C, Bargetzi M, Hoffmann T, Wodnar-Filipowicz A, Signer E,

Speck B, Gratwohl A. Repeated Treatment with Horse Antilymphocyte Globulin for Severe Aplastic Anemia. British Journal of Haematology 1998; 100: 393-400 IF: 3.052

6

22. JR Passweg, P Tiberghien, J-Y Cahn, MR Vowels, BM Camitta, RP Gale, RH Herzig, D Hoelzer, M Horowitz, N. Ifrah, JP Klein, DI Marks, NKC Ramsay, PA Rowlings, DJ Weisdorf, M-J Zhang, AJ Barrett. Graft versus Leukemia Effects in T-lineage and B-lineage Acute Lymphoblastic Leukemia. Bone Marrow Transplantation 1998; 21: 153-8 IF: 2.378

23. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and Marrow Transplantation

Activity in Europe 1996. Bone Marrow Transplantation 1998; 22: 227 IF: 2.378 24. Passweg JR, Hoffmann T, Tichelli A, Favre G, Rohner F, Gratwohl A. Allogeneic Double

Peripheral Stem Cell Transplants for Patients at High Risk of Relapse. Bone Marrow Transplantation 1998; 22: 321 IF: 2.378

25. A Tichelli, D Surbek, H Huxol, C Schmolck, R Wicki, T Hoffmann, A Wodnar-Filipowicz, J

Passweg, P Imbach, W Holzgreve, A Gratwohl. Aufbau einer Nabelschnurblut-Bank für unverwandte allogene Stammzelltransplantationen. Schweizerische Medizinische Wochenschrift 1998; 128: 1598-1601 IF: 0.770

26. L Infanti, V Spengler, M Trendelenburg, T Hoffmann, G Favre, J Passweg, J Schifferli, A

Tichelli. Spurious blood cell counts in a patient with cryoglobulinemia reversed by the use of citrate anticoagulated blood. Schweizerische Medizinische Wochenschrift 1998; 128: 1608-10 IF: 0.770

27. JR Passweg, A Gratwohl, A Tichelli, T Hoffmann, T Kühne, G Favre, C Nissen, R Herrmann,

P Cornu, B Osterwalder, JA Schifferli, E Signer, B Speck. 25 Jahre Allogene Knochenmarks-transplantation in Basel: 1973-1998 Schweizerische Medizinische Wochenschrift 1998; 128: 1568-74 IF: 0.770

28. T Hoffmann, G Favre, A Gratwohl, J Passweg S Mathys J Borel B Speck A Tichelli.

Optimierung der Ausbeute von Plasmazellen in Knochenmarksaspiraten. Schweizerische Medizinische Wochenschrift 1998; 128: 1611 IF: 0.770

29. Passweg JR, Rowlings PA, Horowitz MM. Related Donor Bone Marrow Transplantation

Therapy for Chronic Myelogenous Leukemia. Hematology/Oncology Clinics of North America 1998; 12:1 (February), 81-92 IF: 2.096

30. G. Favre, J. Passweg, T. Hoffmann, B. Speck, A. Gratwohl, A. Tichelli. Immunphänotyp der

Bastenkrise bei chronisch myeloischer Leukämie. Schweizerische Medizinische Wochenschrift 1998; 128: 1624 IF: 0.770

31. A Tichelli, G Socié, M Henry-Amar, J Marsh, J Passweg, H Schrezenmeier, S McCann, J

Hows, P Ljungman, P Marin, A Raghavachar, A Locasciulli, A Gratwohl, A Bacigalupo. Immunosup-pression is feasible and effective in elderly patients with aplastic anemia: A report from the European Group for Blood and Marrow Transplantation (EBMT). Ann. Int. Med. 1999, 130: 193-201 IF: 11.414

32. Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML,

Horowitz MM, Gordon-Smith EC. Bone marrow transplants for paroxysmal nocturnal hemoglobinuria. British Journal of Haematology 1999, 104: 392-396 IF: 3.052

7

33. G Socié, J Veum-Stone, JR Wingard, D Weisdorf, PJ Henslee-Downey, C Bredenson, JY Cahn, JR Passweg, PA Rowlings, HC Schouten, HJ Kolb, JP Klein. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation: Implications for Cure. 1999 New England Journal of Medicine 1999, 341: 14-21 IF: 31.736

34. J Marsh, H Schrezenmeier, P Marin, O Ilhan,P Ljungman, S McCann, G Socié, A Tichelli, J

Passweg, J Hows, A Raghavachar, A Locasciulli, A Bacigalupo for the European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party. Prospective randomised multicentre study comparing cyclosporin alone with the combination of antithymocyte globulin and cyclosporin for treatment of patients with non-severe aplastic anaemia: a report from the EBMT Severe Aplastic Anaemia Working Party. BLOOD. 1999; 93: 2191-2195. IF: 9.631

35. Philip A Rowlings, Rochelle E. Curtis, Jakob R. Passweg, H. Joachim Deeg, Gérard Socié,

Lois B. Travis, Douglas W. Kingma, Elaine S. Jaffe, Kathy A. Sobocinski, Mary M. Horowitz. Increased Incidence of Hodgkin Disease Following Allogeneic Bone Marrow Transplantation. Journal of Clinical Oncology 1999; 17: 3122-3127 IF: 9.868

36. A Tichelli, J Passweg, T Hoffmann, M Gregor, T Kühne, G Favre, A Wodnar-Filipowicz, A

Gratwohl. Repeated peripheral stem cell mobilization in healthy donors: Time dependent changes in mobilization efficiency. Brit. J. Haematol. 1999; 106:152-8 IF: 3.052

37. A Tyndall, A Fassas, J Passweg, C Ruiz de Elvira, M Attal, P Brooks, C Black, P Durez, J

Finke, S Forman, L Fouillard, D Furst, JA Holmes, D Joske, M Jouet, I Kötter, F Locatelli, HG Prentice, AM Marmont, M Musso, HH Peter, N Schmitz, JA Snowden, K Sullivan, A Tichelli, NM Wulffraat, A Gratwohl. Autologous hematopoetic stem cell transplants for autoimmune disease. Bone Marrow Transplantation 1999; 24: 725-34 IF: 2.378

38. A.Bacigalupo, R. Brand, R. Oneto, B. Bruno, G. Socié, J. Passweg, A. Locasciulli, M.T. Van

Lint, A. Tichelli, S. McCann, J. Marsh, P. Ljungman, J. Hows, P. Marin, H. Schrezenmeier. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000 Jan;37(1):69-80. IF: 3.487

39. T Hoffmann, G de Libero, M Colonna, AWodnar-Filipowicz J Passweg, G Favre, A Gratwohl,

A Tichelli. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Brit. J. Haematol. 2000, 110:525-536 IF: 3.052

40. B Müller, A Tichelli, JR Passweg, C Nissen, A Wodnar-Filipowicz, A Gratwohl. Successful

treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Bone Marrow Transplantation 1999, 23:1205-1208 IF: 2.378

41. A Gratwohl, J Passweg, H Baldomero , J Hermans. Blood and Marrow Transplantation

Activity in Europe 1997. Bone Marrow Transplantation, 1999; 24:231-47 IF: 2.378 42. J Libura, T Hoffmann, JR Passweg, M Gregor, G Favre, A Tichelli, A Gratwohl. Graft versus

Myeloma after Withdrawal of Immunosuppression in a Patient Progressing after Allogeneic

8

Peripheral Stem Cell Transplantation. Bone Marrow Transplantation 1999; 24: 925-8 IF: 2.378

43. RE Champlin, JR Passweg, MJ Zhang, PA Rowlings, CJ Pelz, KA Atkinson, AJ Barrett, J-Y

Cahn, WR Drobyski, RP Gale, JM Goldman, AGratwohl, EC Gordon-Smith, PJ Henslee-Downey, RH Herzig, JP Klein, AM Marmont, RJ O’Reilly, O Ringdén, S Slavin, KA Sobocinski, B Speck, RS Weiner, MM Horowitz. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings. Advantage of T-cell antibodies with narrow specificities BLOOD 2000; 95:3996-4003 IF: 9.631

44. G Favre-Schmuziger, S Hofer, J Passweg, A Tichelli, T Hoffmann, B Speck, R Herrmann, A

Gratwohl. Treatment of solid tumors secondary to allogeneic bone marrow transplantation. 1999 Bone Marrow Transplantation 2000; 25:895-98 IF: 2.378

45. S Brodmann, JR Passweg, A Gratwohl, A Tichelli, RC Skoda. Myeloproliferative disorders:

complications, survival and causes of death. Ann. Hematol. 2000; 79:312-318 IF: 1.416 46. C Arber, JR Passweg, U Flückiger, M Pless, M Gregor, A Tichelli, JA Schifferli, A Gratwohl.

C-reactive protein and fever in neutropenic patients. Scand. J. Inf. Dis. 2000, 32:515-520. IF: 1.023

47. Kühne T, Staehelin F, Avoledo P, Gratwohl A, Tichelli A, Passweg J, Imbach P. Erste

Erfahrungen der einfachen und doppelten sequentiellen Hochdosis-Chemotherapie und autologe Stammzelltransplantation bei Kindern mit fortgeschrittenen oder rezidivierten soliden Tumoren. Schweiz. Med. Wschr. 2000; 130:419-25. IF: 0.770

48. Passweg JR, Baldomero H, Gmür J, Bargetzi M, Cavalli F, Ghielmini M, Helg C, Hess U,

Herrmann R, Jost L, Kovacsovic T, Kühne T, Leibundgut K, Leyvraz S, Nenadov-Beck N, Perrey L, Schanz U, Seger R, Starobinski M, Tichelli A, Tobler A, Wernli M, von Rohr A, von Fliedner VE, Gratwohl A, Chapuis B for the Swisstransplant Working Group Blood and Marrow Transplantation (STABMT). Hemopoetic Stem Cell Transplant Activity in Switzerland 1997 / 1998. A Report by the STABMT. Schweiz Med Wochenschr 2000;130:1027–33 IF: 0.770

49. Biedermann B, Landmann C, Kann R, Passweg J, Solèr M, Lohri A, Rochlitz C, Herrmann R,

Pless M. Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer. Radiother Oncol. 2000; 56:169-173. IF: 2.838

50. James M Habicht, Jakob Passweg, Thomas Kuehne, Kurt Leibundgut, Hans-Reinhard

Zerkowski. Successful local excision and long-term survival for invasive pulmonary aspergillosis during neutropenia. J. Thorac. Cardiovasc. Surg. 2000; 119:1286-7 IF: 2.842

51. A. Bacigalupo, R. Oneto, B. Bruno, G. Socié, J. Passweg, A. Locasciulli, M.T. Van Lint, A.

Tichelli, S. McCann, J. Marsh, P. Ljungman, J. Hows, P. Marin, H. Schrezenmeier. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow Transplantation. Acta Haematologica 2000; 103:19-25 IF: 1.252

9

52. JR Passweg, T Kühne, M Gregor, G Favre, P Avoledo, A Tichelli, A Gratwohl. Increased Stem Cell Dose, as Obtained Using Currently Available Technology, may not be Sufficient for Engraftment of Haploidentical Stem Cell Transplants. Bone Marrow Transplantation, 2000;26:1033-6. IF: 2.378

53. M. Trendelenburg, S. Buechner, J. Passweg, A. Raetz Bravo, A. Gratwohl: Disseminated

scabies evolving in a patient undergoing induction chemotherapy for acute myeloblastic leukaemia. Ann. Hematol. 2001: 80:116-118 IF: 1.416

54. C. Mitrache, J.R. Passweg,·J. Libura,·L. Petrikkos, W.O. Seiler, A. Gratwohl, H.B. Stähelin,

A. Tichelli. Anemia: an indicator for malnutrition in the elderly. Ann. Hematol. 2001;80:295–298 IF: 1.416

55. M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, J Finke, HH Peter, J

van Laar, FC Breedveld, WE Fibbe, D Farge, E Gluckman, F Locatelli, A Martini, F Van den Hoogen, L van de Putte, AVN Schattenberg, R Arnold, PA Bacon, P Emery, I Espigado, B Hertenstein, F Hiepe, A Kashyap, I Kötter, A Marmont, A Martinez, MJ Pascual, A Gratwohl, HG Prentice, C Black, A Tyndall. Stabilisation or improvement of pregressive skin disease in scleroderma following autologous haemopoietic stem cell transplantation. Ann Rheum Dis 2001;60:577-584 IF: 3.593

56. A Gratwohl, J Passweg, H Baldomero , A Urbano-Ispizua. Blood and Marrow Transplantation

Activity in Europe 1999. Bone Marrow Transplantation 2001; 27:899-916 IF: 2.378 57. Tyndall A, Passweg J, Gratwohl A. Haematopoietic Stem Cell Transplantation in the

Treatment of Severe Autoimmune Diseases 2000 A Meeting Report on Behalf of the European League Against Rheumatism (EULAR), the European Group for Blood and Marrow Transplantation (EBMT), the International Bone Marrow Transplantation Registry ( IBMTR) and the International Autoimmune Disease Stem Cell Project. Ann Rheum Dis 2001; 60:702-7 IF: 3.593

58. Habicht JM, Matt P, Passweg JR, Reichenberger F, Gratwohl A, Zerkowski HR, Tamm M.

Invasive pulmonary aspergillosis: surgery versus medical treatment. The Hematology Journal 2001; 2:250-6

59. JM Evison, P Rickenbacher, R Ritz, A Gratwohl, C Haberthuer, S Elsasser, JR Passweg. ICU

Admission in patients with hematological disease: Incidence, outcome and prognostic parameters. Swiss Medical Weekly 2001 Dec 22;131(47-48):681-6. IF: 0.770

60. Gratwohl A, Passweg J, Baldomero H, Hermans J, Urbano-Ispizua A. Hematopoietic stem cell

transplantation in Europe 1998. Hematol J. 2000;1(5):333-50. IF 3.23 61. Alois Gratwohl, Jakob Passweg, Helen Baldomero, Bruno Horisberger, Alvaro Urbano-

Ispizua. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. British Journal of Haematology; 2002; 117:451 IF: 3.052

62. G Stussi, J Muntwyler, JR Passweg, L Seebach, U Schanz, J Gmuer, A Gratwohl, JD Seebach.

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 2002; 30:87-94 IF 2.378

10

63. Tichelli A, Socie G, Marsh J, Barge R, Frickhofen N, McCann S, Bacigalupo A, Hows J,

Marin P, Nachbaur D, Symeonidis A, Passweg J, Schrezenmeier H; European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann Intern Med. 2002 Aug 6;137(3):164-72. IF: 11.414

64. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J.

Polyoma BK Nephropathy in Renal Transplant Recipients: Risk Factors and Surrogate Markers. N. Engl. J. Med 2002; 347:488-496 IF: 31.736

65. A. Fassas, J.R. Passweg, A. Anagnostopoulos, A. Kazis, T. Kozak, E. Havrdova, E. Carreras,

F. Graus, A. Kashyap, H. Openshaw, M. Schipperus, E. Deconinck, G. Mancardi, A. Marmont, J Hansz, M Rabusin, F.J. Zuazu Nagore, J Besalduch, T. Dentamaro, L. Fouillard, B. Hertenstein, G. La Nasa, M. Musso, F. Papineschi, J.M. Rowe, R. Saccardi, A. Steck, A. Gratwohl, A. Tyndall for the Autoimmune Disease Working Party of the EBMT (European Group of Blood and Marrow Transplantation) Hemopoietic Stem Cell Transplantation for Multiple Sclerosis: a retrospective multicenter study. J. Neurol. 2002; 249:1088-97 IF: 3.345

66. JR Passweg, S Meyer-Monard, M Gregor, G Favre, D Heim, M Ebnoether, A Tichelli, A

Gratwohl. High Stem Cell Dose Will not Compensate for T-Cell Depletion in Allogeneic Non-Myeloablative Stem Cell Transplantation. Bone Marrow Transplantation 2002; 30:267-271 IF: 2.378

67. Alois Gratwohl, Helen Baldomero, Bruno Horisberger, Caroline Schmid, Jakob Passweg, and

Alvaro Urbano-Ispizua. Current trends in hematopoietic stem cell transplantation in Europe. BLOOD 2002 100: 2374-2386 IF: 9.631

68. JM Habicht, M Preiss, J Passweg, P Dalquen, P Matt, H Adler, R Frei, H-R Zerkowski.

Invasive Pulmonary Aspergillosis: Effects of Early Resection in a Neutropenic Rat Model. Eur J Cardiothorac Surg 2002 Nov;22(5):728-32 IF: 1.451

69. Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A. Increasing use of reduced intensity

conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant. 2002; 30(12):813-31. IF: 2.378

70. M J Bargetzi, J Passweg, E Baertschi, A Schoenenberger, C Gwerder, A Tichelli, J Burger, W

Mingrone, R Herrmann, A Gratwohl and M Wernli. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bone Marrow Transplantation. 2003, 31:99-104 IF: 2.378

71. Gratwohl A, Baldomero H, Passweg J, Frassoni F, Niederwieser D, Schmitz N, Urbano-

Ispizua A. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 2003;17(5):941-59 IF: 4.69

72. Matt P, Bernet F, Habicht J, Gambazzi F, Passweg J, Gratwohl A, Tamm M, Zerkowski HR.

Short- and Long-term Outcome after Lung Resection for Invasive Pulmonary Aspergillosis. Thorac Cardiovasc Surg. 2003 Aug;51(4):221-5. IF: 0.802

11

73. JA Snowden, J Passweg, JJ Moore, S Milliken, P Cannell, JM van Laar, R Verburg, J Szer, K

Taylor, D Joske, S Rule, S Bingham, P Emery, R Burt, RM Lowenthal, P Durez, R McKendry, S Pavletic, I Espigado, E Jantunen, A Kashyap, M Rabusin, P Brooks, C Bredeson, A Tyndall. Autologous haemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. Journal of Rheumatology, 2004; 31:482-488. IF: 2.987

74. David Jayne, Jakob Passweg, Alberto Marmont, Dominque Farge, Xiaowu Zhao, Renata

Arnold, Falk Hiepe, Igor Lisukov, Maurizio Musso, Jian Ou-Yang, Judith Marsh, Nico Wulffrat, Juan Besalduch, Sarah J Bingham, Paul Emery, Mats Brune, Athanasios Fassas1, Lawrence Faulkner, Alina Ferster, Christoph Fiehn, Loic Fouillard, Antonella Geromin, Hildgard Greinix, Marco Rabusin, Riccardo Saccardi, Peter Schneider, Felix Zintl, Alois Gratwohl, Alan Tyndall for the European Group for Blood and Marrow Transplantation and European League Against Rheumatism Registry. Autologous stem cell transplantation for Systemic Lupus Erythematosus. Lupus 2004, 13:168-176 IF: 1.774

75. Jakob R. Passweg, Irwin Walker, Kathleen A. Sobocinski, Brian J. Bolwell, Matthew H.

Carabasi, Enric Carreras, Jan J. Cornelissen, Juergen Finke, Robert Peter Gale, John M. Goldman, Alois Gratwohl, Osman Ilhan, Hans-Jochem Kolb, Mark R. Litzow, Dipnarine Maharaj, Philip L. McCarthy, Emilio. Montserrat, Ricardo Pasquini, Bernard Rio, Harry C. Schouten, Karen Seiter, Richard Szydlo, John P. Klein, Mary M. Horowitz, Sergio A. Giralt. Validation and Extension of the EBMT Risk Score for Patients with Chronic Myeloid Leukemia (CML) Receiving Allogeneic Haematopoietic Stem Cell Transplants. From the Chronic Leukemia Working Committee of the International Bone Marrow Transplant Registry (IBMTR), Health Policy Institute, Medical College of Wisconsin, Milwaukee, Wisconsin British Journal of Haematology, 2004, 125, 613–620 IF 4.08

76. Andreas S. Buser, Dominik Heim, Christoph Bucher, André Tichelli, Alois Gratwohl and

Jakob R. Passweg. High Dose Chemotherapy (BEAM) for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma Bone Marrow Transplantation 2004 May;33(10):1011-4. IF 2.64

77. J.R. Passweg, M. Rabusin, M. Musso, Y. Beguin, S. Cesaro, G. Ehninger, I Espigado, A

Iriondo, L. Jost, V. Koza, S Lenhoff, I. Lisukov, F. Locatelli, A. Marmont, P. Philippe, C. Pilatrino, P. Quartier, J Stary, P. Veys, J. Vormoor, A Wahlin, F. Zintl, C. Bocelli-Tyndall, A. Tyndall, A. Gratwohl for the Autoimmune Disease Working Party of the EBMT. Hematopoetic Stem Cell Transplantation for Refractory Autoimmune Cytopenia. British Journal of Haematology 2004 125: 749–755 IF 4.08

78. N Regamey, V. Hess, J. Passweg, C. Hess, P. Erb, J. Steiger, G. Cathomas and M. Tamm.

Infection with Human Herpesvirus 8 and transplant-associated gammopathy. Transplantation 2004;77(10):1551-4. IF 3.88

79. D Farge, J Passweg, J.M. van Laar, Z Marjanovic, C Besenthal, J Finke, HH Peter, FC

Breedveld, WE Fibbe ,C Black ,C Denton, I Koetter, F Locatelli, A Martini, AVN Schattenberg, L van den Hoogen, L van de Putte, F Lanza, R Arnold, P Bacon, S Bingham, F Ciceri, B Didier, JL Diez-Martin, P Emery, W Feremans, B Bertenstein, F Hiepe, R. Luosujärvi, A Leon Lara, A Marmont, A Martinez, H Pascual Cascon, C Bocelli-Tyndall, E

12

Gluckman, A Gratwohl, A Tyndall AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE TREATMENT OF SYSTEMIC SCLEROSIS: an extended report from the EULAR/EBMT registry Ann Rheum Dis. 2004;63(8):974-81. IF 6.96

80. J.-M. Tiercy, J. Passweg, A. van Biezen, A. Zander, N. Kröger, A. Gratwohl, B. Chapuis, C.

Helg, L. Brinch, J. Cornelissen, M. Oudshoorn, T. Ruutu, L. Volin, D. Niederwieser and E. Roosnek. On behalf of the CLWP. Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplantation 2004; 34(3):249-55. IF 2.64

81. Kostova G, Heim D, Passweg J, Buser A, Tichelli A, Gratwohl A. Cytopenia and

hematopoietic recovery after low intensity conditioning transplants. Croat Med J. 2004; 45(4):445-50. IF 0.8

82. B. Seifert, J.R. Passweg, D. Heim, A. Rovo, S. Meyer-Monard, S Buechner, A. Tichelli,

A. Gratwohl. Complete remission of alopecia universalis after allogeneic hematopoetic stem cell transplantation. Blood 2005 Jan 1;105(1):426-7 IF 10.13

83. Jakob R. Passweg, André Tichelli, Sandrine Meyer-Monard, Dominik Heim, Martin Stern,

Thomas Kühne, Geneviève Favre, Alois Gratwohl. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 2004, Nov;18(11):1835-8. IF 6.61

84. Romaine Viollier, Jakob Passweg, Michael Gregor, Geneviève Favre, Thomas Kühne,

Catherine Nissen, Alois Gratwohl, André Tichelli. Quality-adjusted survival analysis shows Differences in Outcome after Immunosuppression or Bone Marrow Transplantation in Aplastic Anemia Annals of Hematology 2005 Jan;84(1):47-55. IF 2.25

85. Azzola A, Passweg JR, Habicht JM, Bubendorf L, Tamm M, Gratwohl A, Eich G. Use of

Lung Resection and Voriconazole for Successful Treatment of Invasive Pulmonary Aspergillus ustus Infection. J Clin Microbiol. 2004 Oct;42(10):4805-8. IF 3.54

86. J.R. Passweg, K Orchard, A. Buergi, A. Gratwohl, R Powles, J. Goldman, J. Apperley, J

Mehta. Autologous/Syngeneic Stem Cell Transplantation to treat refractory GvHD. Bone Marrow Transplantation 2004; 34: 995-998 IF 2.64

87. Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, Farge D, Fassas A, Finke J,

Furst D, Lassus M, Mancardi G, Miniati I, Mini E, Pagliai F, Passweg J, Pignone A, van Laar JM, Bocelli -Tyndall C, Matucci-Cerinic M. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplantation 2004 Nov;34(10):877-81. IF 2.64

88. Ralph Winterhalder, Simone Deschler-Marini, Christine Landmann, Roger Kann, Jakob

Passweg, Richard Herrmann, Miklos Pless. Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I–IIIB): a phase II study. Radiotherapy and Oncology 73 (2004) 321–324 IF 3.3

13

89. Alessandro Lugli, Monika Ebnoether, Sergio B. Cogliatti, Alois Gratwohl , Jakob Passweg, Urs Hess, Wolfgang Korte, Hanne Hawle, Marianne Tinguely, Bettina Borisch, Sara Mach-Pascual, Silke Von Jürgensonn, André Tichelli and Stephan Dirnhofer Morphologic bone marrow response to Imatinib mesylate (Glivec®) in chronic myelogenous leukemia (CML) patients: Proposal of a response score. Human Pathology 2005 Jan;36(1):91-100. IF 2.55

90. F. Waechter, J. Passweg, M. Tamm, R. Herrmann, M. Pless, Progress in palliative

chemotherapy of non small-cell lung cancer (NSCLC)? Effects of modern chemotherapy regimens in the past decade. Chest 2005; 127:738–747 IF: 4.0

91. Alois Gratwohl, M.D., Jakob Passweg, M.D., M.S., Chiara Bocelli- Tyndall, Ph.D., Athanasios

Fassas, M.D., Jackob M van Laar, M.D., Dominique Farge, M.D., Marino Andolina, M.D, Renate Arnold, M.D., Enric Carreras, M.D., Jürgen Finke, M.D., Ina Kötter, M.D., Tomas Kozak,M.D., Igor Lisukov, M.D., Bob Löwenberg, M.D., Ph.D., Alberto Marmont, M.D., John Moore, MB.BS., M.D., Riccardo Saccardi, M.D., John A Snowden J, M.D., Frank van den Hoogen, M.D., Nico M. Wulffraat,M.D., Xiao Wwu Zhao, M.D., Alan Tyndall,M.D., for the Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)) AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES. IMPACT OF CONDITIONING INTENSITY ON DISEASE PROGRESSION INAUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES. Bone Marrow Transplantation 2005; 35:869-880 IF 2.6

92. G. Stussi, K. Huggel, U. Schanz, J.R. Passweg, J.D. Seebach LEVELS OF ANTI A/B

ANTIBODIES AFTER ABO-INCOMPATIBLE HEMATOPOIETIC STEM CELL TRANSPLANTATION. Transplant Proc. 2005 Mar;37(2):1385-7. IF 0.8

93. Robert Kralovics, Ph.D., Francesco Passamonti, M.D., Andreas S. Buser, M.D., Soon-Siong

Teo, B.S., Ralph Tiedt, Ph.D., Jakob R. Passweg, M.D., Andre Tichelli, M.D., Mario Cazzola, M.D., and Radek C. Skoda, M.D. A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders. New Engl J Med. 2005, 352:1779-1790 IF 51.3

94. Crawley C, Szydlo R, Lalancette M, Bacigalupo A, Lange A, Brune M, Juliusson G, Nagler A,

Gratwohl A, Passweg J, Komarnicki M, Vitek A, Mayer J, Zander A, Sierra J, Rambaldi A, Ringden O, Niederwieser D, Apperley JF. Outcomes of reduced intensity transplantation for chronic myeloid leukaemia: an analysis of prognostic factors from the chronic leukemia working party of the EBMT. Blood. 2005;106(9):2969-76. IF 10.37

95. Alicia Rovó, Sandrine Meyer-Monard, Dominik Heim, Caroline Arber, Jakob R. Passweg,

Alois Gratwohl and André Tichelli No evidence of plasticity in hair follicles of recipients after allogeneic hematopoietic stem cell transplantation Experimental Hematology 2005, 33 (8):909-911 IF 3.2

96. A. Tietz; R. Frei; M. Dangel; D. Bolliger; J. Passweg; A. Gratwohl; A.F. Widmer. Octenidine

hydrochloride for the care of central-venous catheter insertion sites in the severely immunocompromised host. Infect Control Hosp Epidemiol 2005;26:703-707. IF: 2.24

97. M. Weisser, Ch. Rausch, A. Droll, M. Simcock, P. Sendi, I. Steffen, C. Buitrago, S. Sonnet, A.

Gratwohl, J. Passweg, U. Fluckiger. Galactomannan does not Precede Major Signs on

14

Pulmonary CT Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies. Clin Infect Dis 2005 Oct 15;41(8):1143-9. IF 6.19

98. Simone Cesaro, Rosi Oneto, Chiara Messina, Brenda E. Gibson, Isabelle Hirsch,Colin

Steward, Eliane Gluckman, Elisabeth Korthof , Marc A. Boogaerts, C.Vermylen, Paul Veys, Judith Marsh, Isabel Badell Serra, Carole Coze, Tayfun Güngör, Dietrich Niethammer, Pierre Bordigoni, Cecilia Oswald, Claudio Favre, Jakob Passweg and Giorgio Dini for the EBMT Severe Aplastic Anemia and Pediatric Diseases Working Party. Hematopoietic stem cell transplantation for Shwachman–Diamond Disease: a study from the European Group For Blood and Marrow Transplantation (EBMT) Br J Haematol. 2005 Oct;131(2):231-6. IF 4.5

99. A Bacigalupo ,F Locatelli ,G Dini ,J Marsh ,G Socié ,S Maury ,A Locasciulli ,S Cesaro ,J

Passweg. FLUDARABINE , CYCLOPHOSPHAMIDE AND ANTI-THYMOCYTE GLOBULIN (ATG) FOR ALTERNATIVE DONOR TRANSPLANTS IN ACQUIRED APLASTIC ANEMIA (SAA): A REPORT FROM THE EBMT-SAA WORKING PARTY. Bone Marrow Transplant. 2005 Dec;36(11):947-50. IF 2.6

100. MT Martinez, Ch Bucher, G Stussi, D Heim, A Buser, DA Tsakiris, A Tichelli, A

Gratwohl, JR Passweg. Transplant associated Microangiopathy (TAM) in recipients of allogeneic hematopoetic stem cell transplants. Bone Marrow Transplant 2005: 36; 993–1000 IF 2.6

101. Arber C, Buser A, Heim D, Gratwohl A, Tichelli A, Passweg JR. Cyclosporine-responsive

thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome Eur J Haematol 2006 Mar;76(3):255-257 IF 2.24

102. U.Koehl, R.Esser, S.Zimmermann; T.Tonn, R.Kotchetkov, T.Bartling, J.Sörensen, H.-

P.Grüttner, P.Bader, E.Seifried, H.Martin, P.Lang, J.R.Passweg, T.Klingebiel, D.Schwabe.Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klin Padiatr. 2005 Nov;217(6):345-350. IF: 1.06

103. Jörg D. Seebach, Georg Stussi, Jakob R. Passweg, Fausto R Loberiza Jr, James L.

Gajewski, Armand Keating, Martin Goerner, Philip A. Rowlings, Pierre Tiberghien, Gerald J. Elfenbein, Robert Peter Gale, Jon J. van Rood, Vijay Reddy, Eliane Gluckman, Brian J. Bolwell, Thomas R. Klumpp, Mary M. Horowitz, Olle Ringdén, A. John Barrett, ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited. Biol Blood Marrow Transplant. 2005 Dec;11(12):1006-13. IF: 3.46

104. Sandrine Meyer-Monard, Valérie Parlier, Jakob Passweg, Dominique Mühlematter, Urs

Hess, Mario Bargetzi, Thomas Kühne, Bernard Chapuis, Alois Gratwohl Martine Jotterand and André Tichelli. Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia, Leukemia 2006 20(2):247-53 IF: 8.64

105. P Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, T Demirer, G Dini, H Einsele, A

Gratwohl, A Madrigal, D Niederwieser, J Passweg, V Rocha, R Saccardi, H Schouten, N Schmitz, G Socie, A Sureda, and J Apperley for the European Group for Blood and Marrow Transplantation Allogeneic and autologous transplantation for haematological diseases, solid

15

tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant, 2006 Mar;37(5):439-49. IF: 2.6

106. Jakob R. Passweg, MD MS, Waleska S. Pérez, MPH, Mary Eapen, MD, MS, Bruce M.

Camitta, MD, Eliane Gluckman, MD, FRCP, Wolfgang Hinterberger, MD, Jill M. Hows, MD, Judith C.W. Marsh, MD, Ricardo Pasquini, MD, Hubert Schrezenmeier, MD, Gerard Socié, MD, PhD, Mei-Jie Zhang, PhD, and Christopher Bredeson, MD, MSc. Bone Marrow Transplants from Mismatched Related and Unrelated Donors for Severe Aplastic Anemia Bone Marrow Transplant. 2006 Apr;37(7):641-9. IF: 2.6

107. Heim D, Friess D, Christen S, Stussi G, Meyer-Monard S, Tichelli A, Passweg JR,

Gratwohl A. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia. Leukemia 2006 20: 898-900 IF 8.63

108. Petrig C, Bassetti S, Passweg J, Marsch S. Acute respiratory failure due to sweet syndrome.

Am J Med Sci. 2006 Mar;331(3):159-61. 109. Alicia Rovó, André Tichelli, Jakob R Passweg, Dominik Heim, Sandrine Meyer-Monard,

Wolfgang Holzgreve, Alois Gratwohl, Christian De Geyter Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cells transplantation is associated with age, time interval since transplantation and absence of chronic GvHD. 2006 Blood. 2006 108(3):1100-5. IF 10.9

110. J. Passweg, H. Baldomero, B. Chapuis, K. Leibundgut, U. Schanz, A. Gratwohl, for the

STABMT Board. Haematopoietic stem cell transplantation in Switzerland. Report from the Swiss Transplant Working Group for Blood and Marrow Transplantation (STABMT) Registry 1997–2003 SWISS MED WKLY 2006;136:50–58 IF: 1.31

111. Yves Chalandon, Jean-Marie Tiercy, Urs Schanz, Tayfun Guengoer, Reinhard Seger, Joerg

Halter, Claudine Helg, Bernard Chapuis, Alois Gratwohl, Andre Tichelli, Grazia Nicoloso de Faveri, Eddy Roosnek, Jakob R Passweg on behalf of the SwissTransplant Working Group for Blood and Marrow Transplantation (STABMT). IMPACT OF HIGH RESOLUTION MATCHING IN ALLOGENEIC UNRELATED DONOR STEM CELL TRANSPLANTATION IN SWITZERLAND and the Swiss National Donor Registry, Bone Marrow Transplant 2006 May;37(10):909-16. IF 3.0

112. Florence Bettens, Jakob Passweg, Alois Gratwohl, Yves Chalandon, Claudine Helg,

Bernard Chapuis, Urs Schanz, Jolanta Libura, Eddy Roosnek, Jean-Marie Tiercy .Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation, Transplantation 2006 May 15;81(9):1261-1267. IF: 3.64

113. Martin Stern, Jakob R. Passweg, Anna Locasciulli, Gerard Socié, Hubert Schrezenmeier,

Albert N. Békássy, Monica Fuehrer, Jill Hows, Elisabeth T. Korthof, Shaun McCann, André Tichelli, Nicholas C. Zoumbos, Judith C.W. Marsh, Andrea Bacigalupo, Alois Gratwohl. Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Transplantation. 2006 Jul 27;82(2):218-226. IF: 3.64

16

114. Martin Stern, Jakob Passweg, Jean-Marie Tiercy, Alexander Genitsch, Sandrine Meyer-Monard, Dominik Heim, André Tichelli, Alois Gratwohl, Catherine Nissen-Druey. Human Leukocyte Antigen DR15 Is Associated with Reduced Relapse Rate and Improved Survival after Human Leukocyte Antigen-Identical Sibling Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation 2006; 12:1169-1175 IF: 3.38

115. Jill Hows MD, Jakob R Passweg MD, André Tichelli MD, Anna Locasciulli, MD, Richard

Syzdlo, PhD, Andrea Bacigalupo MD, Niels Jacobson MD, Per Ljungman MD, Jacqueline Cornish MD, Ben Bradley PhD MD, Gérard Socié PhD MD. For the IMUST Study Participating Centers* and the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT) LONG-TERM OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM SIBLING AND UNRELATED DONORS. A PROSPECTIVE FOLLOW-UP STUDY. Bone Marrow Transplant 2006; 2006 Dec;38(12):799-805. IF 3.0

116. Socie G, Mary JY, Schrezenmeier H, Marsh J, Bacigalupo A, Locasciulli A, Fuehrer M,

Bekassy A, Tichelli A, Passweg J. Granulocyte-stimulating factor and severe aplastic anemia A survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2007 Apr 1;109(7):2794-6. IF: 10.9

117. S McCann, J Passweg, A Bacigalupo, A Locasciulli, F Locatelli, J Ryan, H Schrezenmeier

and M Lawler The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplant 2007 39: 109-114 IF 3.0

118. R Saccardi, T Kozak, C Bocelli-Tyndall, A Fassas, A Kazis, E Havrdova, E Carreras, A

Saiz, B Löwenberg, PAW te Boekhorst, F Gualandi, H Openshaw, G Longo, F Pagliai, L Massacesi, E Deconink, J Ouyang, FJZ Nagore, J Besalduch, IA Lisukov, A Bonini, E Merelli, S Slavin, A Gratwohl, J Passweg, A Tyndall, AJ Steck, M Andolina, M Capobianco, JLD Martin, A Lugaresi, G Meucci, RA Sa´ez, RE Clark, MN Fernandez, L Fouillard, B Herstenstein, V Koza, E Cocco, H Baurmann3and GL Mancardi on behalf of the Autoimmune Diseases Working Party of EBMT. Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Multiple Sclerosis 2006; 12: 814-823 IF 3.26

119. Anna Locasciulli, Rosi Oneto, Andrea Bacigalupo, Gerard Socié, Elisabeth Korthof, Albert

Bekassy, Hubert Schrezenmeier, Jakob Passweg, MoniKa Führer on the Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group (SAA-WP, BMT). Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT) Haematologica 2007;91:11-18 IF: 5.98

120. Richard E. Champlin, MD, Waleska S. Pérez, Jakob R. Passweg, MD, MS, John P. Klein,

PhD, Bruce M. Camitta, MD, Eliane Gluckman, MD, Christopher N. Bredeson, MD, MSc, Mary Eapen, MD, MS and Mary M. Horowitz, MD, MS. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. BLOOD 2007;109 4582-4585 IF: 10.9

17

121. Stussi G, Mueller R, Passweg J, Schanz U, Rieben R, Seebach J. AB0 blood group incompatible haematopoietic stem cell transplantation and xenograft rejection. Swiss Med Wkly. 2007 Jan 13;137(1-2):13-20. IF: 1.31

122. Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G,

Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A. High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation. Bone Marrow Transplant. 2007 Mar;39(6):335-40. IF: 3.0

123. Dobr T, Passweg J, Weber C, Tichelli A, Heim D, Meyer J, Gratwohl A, Waltimo T. Oral

health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantation. Eur J Haematol. 2007 Jun;78(6):495-9. IF 2.24

124. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E,

Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Scahttenberg AV, Socie G, Eapen M. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia: A report from the European Group for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research. Blood. 2007 Aug 15;110(4):1397-400. IF: 10.9

125. Christoph Bucher, Martin Stern, Andreas Buser, Dominik Heim, Michael Paulussen, Joerg

Halter, Dimitrios Tsakiris, Armin Droll, Sandrine Meyer-Monard, Andre Tichelli, Jakob Passweg, and Alois Gratwohl Role of primacy of birth in HLA-identical sibling transplantation. BLOOD, 2007; 110:468-9 IF: 10.9

126. Arber C, Buser A, Heim D, Weisser M, Tyndall A, Tichelli A, Passweg J, Gratwohl A.

Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment.Bone Marrow Transplant. 2007 Sep;40(6):597-8. IF: 3.0

127. Tiercy JM, Nicoloso G, Passweg J, Schanz U, Seger R, Chalandon Y, Heim D, Güngör T,

Schneider P, Schwabe R, Gratwohl A.The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant. 2007 Sep;40(6):515-22. IF: 3.4

128. André Tichelli, Christoph Bucher, Alicia Rovó, Georg Stussi, Martin Stern, Michael

Paulussen, Jörg Halter, Sandrine Meyer-Monard, Dominik Heim, Dimitrios Tsakiris, Barbara Biedermann, Jakob Passweg, Alois Gratwohl. Premature Cardiovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation BLOOD 2007 Nov 1;110(9):3463-71 IF: 10.43

129. Eric P Cohen, MD, Amy A Irving, BA, William R Drobyski, MD, John P Klein, PhD,

Jakob Passweg, MD, Julie-An M Talano, MD, Mark B Juckett, John E Moulder , PhD. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Rad Oncol Biol Phys 2008 Apr 1;70(5):1546-51. IF: 4.64

18

130. Suva D, Passweg J, Arnaudeau S, Hoffmeyer P, Kindler V. In Vitro Activated Human T Lymphocytes Very Efficiently Attach to Allogenic Multipotent Mesenchymal Stromal Cells and Transmigrate Under Them J. Cell. Physiol. 9999: 1–7, 2007. IF: 4.31

131. Stussi G, Mueller RJ, Passweg J, Schanz U, Rieben R, Seebach JD. ABO blood group

incompatible haematopoietic stem cell transplantation and xenograft rejection. Swiss Med Wkly. 2007 Mar 2;137 Suppl 155:101S-108S. IF: 1.43

132. Viollier R, Socié G, Tichelli A, Bacigalupo A, Korthof ET, Marsh J, Cornish J, Ljungman

P, Oneto R, Békássy AN, Fuehrer M, Maury S, Schrezenmeier H, van Lint MT, Wojcik D, Locasciulli A, Passweg JR. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant. 2008 Jan;41(1):45-50. IF:3.4

133. Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S,

Halter J, Tichelli A, Gratwohl A. Patient and product factors affecting platelet transfusion results. Transfusion. 2008 Apr;48(4):681-7 IF 3.48

134. Terrettaz M, Verholen F, Passweg J, Knipp S, Burkhard PR, Chalandon Y. Steroid-

responsive cauda equina syndrome associated with GvHD after allogeneic hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplantation 2008 Feb;41(3):315-6. IF: 3.4

135. Went P, Tzankov A, Schwaller J, Passweg J, Roosnek E, Huard B. Role of the tumor

necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases. Exp Hematol. 2008 May;36(5):533-4. IF:3.2

136. Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A,

Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008 Aug;93(8):1203-10. Epub 2008 Jun 12. IF: 5.98

137. S. Bieri, E. Roosnek, C. Helg, F.Verholen, D.Robert , B. Chapuis, J. Passweg, R.

Miralbell, Y. Chalandon; Health-related quality of life and social issues after allogeneic haematopoietic stem cell transplantation for haematological disease. 2008 Bone Marrow Transplant. 2008 Dec;42(12):819-27. IF: 3.4

138. Chevallier-Ruggeri P, Passweg JR, Lambert J-F. Myélome Multiple Atypique – la

gammapathie monoclonale à ne pas banaliser. Swiss Med Forum. 2008;8(38):713-714

139. Theocharides A, Passweg JR, Medinger M, Looser R, Li S, Hao-Shen H, Buser AS, Gratwohl A, Tichelli A, Skoda RC. The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica. 2008; 93(12):1890-3. PMID: 18790796 IF: 5.98

140. M. Stern, R. Brand, T. de Witte, A. Sureda, V. Rocha, J. Passweg, H. Baldomero, D.

Niederwieser and A. Gratwohl. Female-Versus-Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation. American Journal of Transplantation 2008, Vol 8, 10, 2149-2157 IF: 6.56

19

141. Uderzo C, Pillon M, Tridello G, Dini G, Urban C, Corti P, Zintl F, Fagioli F, Messina C,

Verdeguer A, Faraci M, Fedeli S, Tana F, Tichelli A, Passweg J, Rovelli A. Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: Report from the EBMT Paediatric Diseases and Late Effects Working Parties. Pediatr Transplant. 2008 Sep 26. [Epub ahead of print] IF: 1.86

142. Stephen P. Robinson, Anna Sureda, Carmen Canals, Goli Taghipour, Nigel Russell,

Dolores Caballero, Andrea Bacigalupo, Iriondo Arturo, Gordon Cook, Andrew Pettitt, Renato Fanin, Carmen Martinez, Gerard Socie, Francesca Bonifazi, Alberto Bosi, Fiona Clark, Mauricette Michallet, Alessandro Rambaldi, Angelo Carella, Ildefonso Espigado, Ann Hunter, Lars Vindelov, Effie Liakopoulou, Johan Maertens, Jakob Passweg, Rodrigo Martino and Norbert Schmitz on behalf of the Lymphoma Working Party of the EBMT. Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin’s disease: Identification of prognostic factors predicting outcome. Hematologica 2009;94(2):230-8 IF: 5.98

143. S Meyer-Monard, J Passweg, C Troeger, H-P Eberhard, E Roosnek, G Nicoloso de Faveri, Y Chalandon, A Rovo, O Irion, W Holzgreve, A Gratwohl, CHMüller, A Tichelli, J-M Tiercy; Swiss cord blood banks recruit different HLA alleles and haplotypes than bone marrow donor registries. Bone Marrow Transplant 2009 43: 771-778 IF: 3.4

144. S Meyer-Monard, J Passweg, U Siegler, C Kalberer, U Koehl, A Rovó, J Halter, M Stern,

D Heim, J Rischewski, A Gratwohl, A Tichelli. Clinical grade purification of NK cells in haploidentical hematopoietic stem cell transplantation. Transfusion. 2009 Feb;49(2):362-71. IF 3.48

145. Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber

C, Buser A, Meyer-Monard S, Tichelli A, Gratwohl A. Aplastic Anemia and concomitant Autoimmune Diseases. Ann Hematol. 2009 [Epub ahead of print] IF: 2.45

146. Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gmür J, Gratwohl A, Schanz U,

Passweg JR, Seebach JD. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica. 2009 Jan 14. [Epub ahead of print] IF: 5.98

147. Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, O'Riordan J,

Locasciulli A, Socié G, Kelly A, Schrezenmeier H, Marin P, Tichelli A, Passweg JR, Dickenson A, Ryan J, Bacigalupo A; from the Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol. 2009 Jan 9. [Epub ahead of print] IF: 4.48

148. Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D, Halter J, Christen S, Tsakiris

DA, Droll A, Frei R, Widmer AF, Flückiger U, Passweg J, Tichelli A, Gratwohl A. Infection prevention strategies in a stem cell transplant unit: Impact of change of care in isolation

20

practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality. Eur J Haematol. 2009 Mar 5. [Epub ahead of print] IF: 2.24

149. Horan JT, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J,

Passweg JR, Walters MC, Eapen M. Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. Biol Blood Marrow Transplant. 2009 May;15(5):626-31. IF: 3.38

150. Rigamonti F, Beris P, Sanchez-Pareja A, Meyer P, Ashrafpoor G, Zaza S, Passweg J,

Chalandon Y. Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma. Int J Hematol. 2009 Apr 23. [Epub ahead of print] IF: 1.28

151. Verholen F, Terrettaz M, Roosnek E, Passweg JR, Chalandon Y. Hodgkin's Lymphoma

relapsing after autologous transplantation: Allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back. Eur J Haematol. 2009 Jun 2. [Epub ahead of print] IF: 2.24

152. Burjanadze M, Matthes T, McKee T, Passweg J, Huard B. In situ detection of APRIL-rich

niches for plasma-cell survival and their contribution to B-cell lymphoma development. Histol Histopathol. 2009 Aug;24(8):1061-6. IF: 2.19

153. Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C, Heim D, Passweg JR,

Rischewski J, Paulussen M, Gratwohl A. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplant. 2009 Jun 29. [Epub ahead of print] IF: 3.4

154. Per Ljungman, Marco Bregni, Mats Brune, Jan Cornelissen, Theo de Witte, Giorgio Dini, Hermann Einsele, H Bobby Gaspar, Alois Gratwohl, Jakob Passweg, Christina Peters, Vanderson Rocha, Riccardo Saccardi, Harry Schouten, Anna Sureda, Andre Tichelli, Andrea Velardi, and Dietger Niederwieser for the European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 2009 Jul 6. [Epub ahead of print] IF: 3.4

155. Dudler C, Bargetzi M, Tichelli A, Gratwohl A, Passweg J, Wernli M. DV-ICE, Intensive Induction and Early Transplantation for Adult Patients with Acute Lymphoblastic Leukemia. A Phase II Study. Eur J Haematol. 2009 Jul 9. [Epub ahead of print] IF: 2.24

156. Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP, Ljungman P,

Schattenberg A, Witte TD, Lenhoff S, Jacobs P, Volin L, Iacobelli S, Finke J, Niederwieser D, Guglielmi C. Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT. Bone Marrow Transplant. 2009 Jul 27. [Epub ahead of print] IF: 3.4

21

157. Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T, Dini G, Rocha V, Passweg J, Sureda A, Tichelli A, Niederwieser D; for the European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a Retrospective Analysis. Cancer. 2009 Jul 29. [Epub ahead of print] IF: 5.24

158. Rovó A, Stüssi G, Meyer-Monard S, Favre G, Tsakiris D, Heim D, Halter J, Arber C, Passweg J, Gratwohl A, Tichelli A. Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. Int J Lab Hematol. 2009 Aug 25. [Epub ahead of print] IF: 1.0

159. Sébastien Maury, Andrea Bacigalupo, Paolo Anderlini, Mahmoud Aljurf, Judith Marsh,

Gérard Socié, Rosi Oneto, Jakob R. Passweg on behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT-SAAWP) Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen Haematologica 2009 94: 1312-1315 IF 5.98

160. Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T,

Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Socié G; ATG-Fresenius Trial Group. Collaborators: Schmoor C, Grishina O, Müller Ch, Scheele J, Schilling B, Kaufmann M, Tostmann R, Kollmer A, Nuss S, Wenig C, Finke J, Bertz H, Egger M, Bethge WA, Einsele H, Müller RK, Häntschel M, Ottinger HD, Trenschel R, Stelljes M, Zander AR, Kröger NM, Ayuketang FA, Wolschke C, Schwerdtfeger R, Kaltenhäuser J, Stübig T, Taube RH, Kolbe K, Thomas S, Ullmann A, Schulze-Bergkamen A, Holler E, Hahn J, Bornhäuser M, Kolb HJ, Reibke R, Wandt H, Schaefer-Eckart K, Socie G, Gluckman E, Esperou H, Robin M, Michallet M, Nicolini F, Buzyn A, Rubio MT, Yakoub-Agha I, Jouet JP, Petillon MO, Bordigoni P, Clement L, Salmon A, Feugier P, Ruutu T, Volin L, Juvonen E, Nihtinen A, Remes K, Putkonen M, Itälä M, Kauppila M, Mayer J, Krejci M, Brychtová Y, Koza V, Karas M, Voglova J, Lebavy J, Zak P, Heim D, Gratwohl A, Passweg J, Arber C, Tsakiris A, Linkesch W, Reitter S, Staber PB, Lutz D, Krieger O, Maertens JA, Theunissen K, Boogaerts M, Verhoef G, Rowe J, Rosenvald-Zuckermann T, Shapira M, Or R, Resnik I, Nagler A, Shimoni A, Yerushalmi R, Sierra J, Valcarcel D, Pérez Simón JA, Astorga M, Bosi A, Guidi S, Gratwohl A, Holländer N, Jähnchen E. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol. 2009 Sep;10(9):855-64. Epub 2009 Aug 18. IF: 13.3

161. Ambrosioni J, van Delden C, Krause KH, Bouchuiguir-Wafa C, Nagy M, Passweg J,

Chalandon Y. Invasive microsporidiosis in allogeneic haematopoietic SCT recipients. Bone Marrow Transplant. 2009 Nov 16. [Epub ahead of print] PMID: 19915628 IF: 3.4

162. Piccin A, McCann S, Socié G, Oneto R, Bacigalupo A, Locasciulli A, Marsh J,

Schrezenmeier H, Tichelli A, Hand E, Lawler M, Passweg J. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA

22

of the EBMT. Bone Marrow Transplant. 2009 Nov 16. [Epub ahead of print] PMID: 19915627 IF: 3.4

163. Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, Halter J, Gupta V, Bacigalupo A, Sociè G, Tichelli A, Schrezenmeier H, Marsh J, Passweg J, Rotoli B; on behalf of the Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT). Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol. 2009 Dec 7. [Epub ahead of print] IF: 4.48

164. Gratwohl A, Doehler B, Stern M, Bucher C, Passweg J, Opelz G. Birth order and outcome

after HLA-identical sibling donor transplantation. Blood. 2009 Dec 24;114(27):5569-5570. No abstract available.

165. Huenecke S, Zimmermann SY, Kloess S, Esser R, Brinkmann A, Tramsen L, Koenig M,

Erben S, Seidl C, Tonn T, Eggert A, Schramm A, Bader P, Klingebiel T, Lehrnbecher T, Passweg JR, Soerensen J, Schwabe D, Koehl U. IL-2-driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16- Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion. J Immunother. 2010 Feb 6. [Epub ahead of print]

166. Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y.

Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection. Transpl Infect Dis. 2010 Feb 16. [Epub ahead of print]

167. Passweg J, Baldomero H, Stern M, Bargetzi M, Ghielmini M, Leibundgut K, Duchosal M,

Hess U, Seger R, Buhrfeind E, Schanz U, Gratwohl A. Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect. Swiss Med Wkly. 2010 Mar 26. [Epub ahead of print]

168. Locasciulli A, Bacigalupo A, Bruno B, Montante B, Marsh J, Tichelli A, Socié G, Passweg J; On the Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group (SAA-WP, EBMT). Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party. Br J Haematol. 2010 Apr 29. [Epub ahead of print]

169. Löwenberg B, Beck J, Graux C, van Putten W, Schouten HC, Verdonck LF, Ferrant A, Sonneveld P, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, Breems D, de Muijnck H, Schaafsma R, Verhoef G, Döhner H, Gratwohl A, Pabst T, Ossenkoppele GJ, Maertens J; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German Austrian AML Study Group (AMLSG); Swiss Group for Clinical Cancer Research Collaborative Group (SAKK). Collaborators: Ferrant A, Delannoy A, Maertens J, Verhoef G, Demuynck H, Bosly A, Graux C, Breems DA, Zachee P, Jaeger E, Beck J, Fischer T, von Lilienfeld-Toal M, Glasmacher A, Hartmann F, Grimminger W, Döhner H, Bargetzi M,

23

Wernli M, Gratwohl A, Fey MF, Pabst T, Passweg J, Chalandon Y, Herr A, Wuillemin WA, Stuessi G, Schanz U, Van Der Lelie J, Biemond BJ, De Valk B, Ossenkoppele GJ, Huijgens PC, Wijermans PW, Levin MD, Schaafsma MR, Daenen SM, Vellenga E, Voogt PJ, Schouten HC, Biesma DH, Sonneveld P, Zijlmans J, Jongen-Lavrencic M, De Greef GE, Löwenberg B, Verdonck LF, Kuball J, Van Marwijk Kooy M, Milligan DW, Pocock C, Aldouri M. Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study. Blood. 2010 Apr 1;115(13):2586-91. Epub 2010 Jan 26.

170. Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A, Cesaro S, Shimoni A, Marsh J, Brune M, van Lint MT, Oneto R, Passweg J. Fludarabine, cyclophosphamide, anti-thymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia (SAA): a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010 May 21. [Epub ahead of print]

171. Nabhan SK, Bitencourt M, Duval M, Abecasis M, Dufour C, Boudjedir K, Rocha V, Socie' G, Passweg J, Goi K, Sanders J, Snowden J, Yabe H, Pasquini R, Gluckman E. Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica. 2010 May 21. [Epub ahead of print]

172. Marsh J, Socie G, Tichelli A, Schrezenmeier H, Hochsmann B, Risitano AM, Fuehrer M, Bekassy AN, Korthof ET, Locasciulli A, Ljungman P, Bacigalupo A, Camitta B, Young NS, Passweg J; On behalf of the European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Br J Haematol. 2010 May 26. [Epub ahead of print] No abstract available.

173. Cantoni N, Gerull S, Heim D, Halter J, Bucher C, Buser A, Tsakiris DA, Passweg J, Tichelli A, Stern M, Gratwohl A. Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010 Jun 14. [Epub ahead of print]

174. Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, Maury S, Kurtzberg J, Bonfim C, Aljurf M, Gluckman E, Socié G, Passweg J, Rocha V. Influence of nucleated cell dose on overall survival of unrelated cord blood transplant for patients with severe acquired aplastic anemia: A study by EUROCORD and the Aplastic Anemia Working Party of the EBMT. Biol Blood Marrow Transplant. 2010 Jun 15. [Epub ahead of print]

175. Cesaro S, Marsh J, Tridello G, Rovò A, Maury S, Montante B, Masszi T, Van Lint MT, Afanasyev B, Iriondo Atienza A, Bierings M, Carbone C, Doubek M, Lanino E, Sarhan M, Risitano A, Steinerova K, Wahlin A, Pegoraro A, Passweg J Retrospective Survey on the Prevalence and Outcome of Prior Autoimmune Diseases in Patients with Aplastic Anemia Reported to the Registry of the European Group for Blood and Marrow Transplantation. . Acta Haematol. 2010 Jul 6;124(1):19-22. [Epub ahead of print]

24

176. de la Fuente IG, Ansari M, Rougemont AL, Passweg JR, Gumy-Pause F, Ozsahin H,

Lobrinus JA, Posfay-Barbe KM. ACUTE DISSEMINATED FATAL TOXOPLASMOSIS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION DESPITE ATOVAQUONE PROPHYLAXIS IN A YOUNG MAN. Pediatr Infect Dis J. 2010 Aug 18. [Epub ahead of print] PMID: 20724953

177. Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale RP, Hale GA, Ilhan O, Passweg JR, Ringden O, Sabloff M, Schrezenmeier H, Socie G, Marsh JC. Impact of age on outcomes after transplantation for acquired aplastic anemia using HLA-identical sibling donors. Haematologica. 2010 Sep 17. [Epub ahead of print]

178. Jakob R. Passweg, Aristoteles A. N. Giagounidis, Mathew Simcock, Carlo Aul, Christiane

Dobbelstein, Michael Stadler, Gert Ossenkoppele, Wolf-Karsten Hofmann, Kristina Schilling, André Tichelli and Arnold Ganser on behalf of the Swiss Group for Clinical Cancer Research (SAKK) and the German MDS Study Group Immunosuppressive Therapy for Patients with Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin + Cyclosporine with Best Supportive Care: SAKK 33/99 J Clin Oncol 2010 in press

179. Mueller RJ, Stussi G, Puga Yung G, Nikolic M, Soldini D, Halter J, Meyer-Monard S,

Gratwohl A, Passweg JR, Odermatt B, Schanz U, Biedermann BC, Seebach JD. Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation. Haematologica. 2010 Oct 7. [Epub ahead of print]

180. Marija Vukicevic, Yves Chalandon, Claudine Helg, Thomas Matthes, Carole Dantin, Bertrand Huard, Jakob Passweg and Eddy Roosnek CD56(bright) NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells. Eur J Immunol. 2010 Sep 6. [Epub ahead of print]

181. Kloess S, Huenecke S, Piechulek D, Esser R, Koch J, Brehm C, Soerensen J, Gardlowski

T, Brinkmann A, Bader P, Passweg J, Klingebiel T, Schwabe D, Koehl U. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MiCA. Eur J Immunol. 2010 Sep 21. [Epub ahead of print]

182. Bizzetto R, Bonfim C, Rocha V, Socie' G, Locatelli F, Chan K, Ramirez O, Stein J,

Nabhan S, Miranda E, Passweg J, de Souza CA, Gluckman E. Outcomes after related and unrelated umbilical cord blood transplantation for non-Fanconi hereditary bone marrow failure. Haematologica. 2010 Nov 11. [Epub ahead of print]

183. Fontanet A, Chalandon Y, Roosnek E, Mohty B, Passweg JR. Cotrimoxazole

myelotoxicity in hematopoietic SCT recipients: time for reappraisal.Bone Marrow Transplant. 2010 Nov 22. [Epub ahead of print] No abstract available.

184. Passweg JR, Giagounidis AA, Simcock M, Aul C, Dobbelstein C, Stadler M,

Ossenkoppele G, Hofmann WK, Schilling K, Tichelli A, Ganser A. Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter

25

Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care--SAKK 33/99. J Clin Oncol. 2010 Dec 13. [Epub ahead of print]

185. Tichelli A, Schrezenmeier H, Socié G, Marsh J, Bacigalupo A, Dührsen U, Franzke A,

Hallek M, Thiel E, Wilhelm M, Höchsmann B, Barrois A, Champion K, Passweg JR. A randomized controlled study in newly-diagnosed severe aplastic anemia patients receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the EBMT. Blood. 2011 Jan 13. [Epub ahead of print]

186. Mohty B, Thomas Y, Vukicevic M, Nagy M, Levrat E, Bernimoulin M, Kaiser L, Roosnek E, Passweg J, Chalandon Y. Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2011 Mar 21. [Epub ahead of print]

187. Mohty B, Bel M, Vukicevic M, Nagy M, Levrat E, Meier S, Grillet S, Combescure C, Kaiser L, Chalandon Y, Passweg J, Siegrist CA, Roosnek E. Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica. 2011 Mar 21. [Epub ahead of print]

188. Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J, de

Witte T, Ljungman P, McDonald F, McGrath E, Passweg J, Peters C, Rocha V, Slaper-Cortenbach I, Sureda A, Tichelli A, Apperley J. Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2011 Apr 11. [Epub ahead of print] PMID: 21483006 May 20;29(15):1980-6.

189. Bieri S, Roosnek E, Ozsahin H, Huguet S, Ansari M, Trombetti A, Helg C, Chapuis B, Miralbell R, Passweg J, Chalandon Y. Outcome and risk factors for late-onset complications twenty-four months beyond allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2011 Apr 28. doi: 10.1111/j.1600-0609.2011.01638.x. [Epub ahead of print] 2011 Aug;87(2):138-47

190. Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A. 2011 May 4. [Epub ahead of print]; 2011 Sep;17(17-18):2221-30.

191. Matthes T, Dunand-Sauthier I, Santiago-Raber ML, Krause KH, Donze O, Passweg J, McKee T, Huard B. Production of the plasma-cell survival factor APRIL peaks in myeloid precursor cells from human bone marrow. Blood. 2011 Jun 3. [Epub ahead of print] Blood. 2011 Aug 18;118(7):1838-44. Epub 2011 Jun 3.

192. Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ. Effect of stem cell source on outcomes after adult unrelated donor transplantation in severe aplastic anemia. Blood. 2011 Jun 15. [Epub ahead of print] Blood. 2011 Sep 1;118(9):2618-21. Epub 2011 Jun 15.

193. Ansari M, Vukicevic M, Rougemont AL, Moll S, Parvex P, Gumy-Pause F, Chalandon

Y,Passweg J, Ozsahin H, Roosnek E Do NK Cells Contribute to the Pathophysiology of Transplant-Associated Thrombotic Microangiopathy? Am J Transplant. 2011 Jun 30. doi: 10.1111/j.1600-6143.2011.03617.x. [Epub ahead of print]

26

194. Schneider T, Halter J, Heim D, Passweg J, Stern M, Tichelli A, Weisser M, Gerull S. Pre-

emptive diagnosis and treatment of fungal infections-evaluation of a single-centre policy. Clin Microbiol Infect. 2011 May 31. doi: 10.1111/j.1469-0691.2011.03589.x. [Epub ahead of print] PMID: 21729194

195. Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M. Donor characteristics affecting graft failure, graft vs. Host disease and survival after unrelated donor transplantation with reduced intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant. 2011 Dec;17(12):1869-73

196. Gabay C,Bel M,Combescure C,Ribi C, Meier S, Posfay-Barbe K, Grillet S, Seebach JD, Kaiser L, Wunderli W, Guerne PA, Ambrosioni J, Berney T, Calmy A, Chalandon Y, Charvat S, Delhumeau-Cartier C, Demeules J, Dietrich PY, Favet L, George AC, Giostra E, Hadaya K, Hirschel B, Martin PY, Mentha G, Mohty B, Morard I, Nagy M,Nguyen A, Noble S, Passweg J, Roosnek E, Sealy G, Soccal P, Thomas Y, van Delden C, Verdon M, Villard J, Yerly S. Siegrist CA; H1N1 Study Group. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum. 2011 Jun;63(6):1486-96. doi: 10.1002/art.30325. PMID: 21384334

197. Medinger M, Buser A, Stern M, Heim D, Halter J, Rovo A, Tzankov A, Tichelli A, Passweg J. Aplastic anemia in association with a lymphoproliferative neoplasm: Coincidence or causality? Leuk Res. 2012 Feb;36(2):250-1 PMID: 21962338

198. Bettens F,Passweg J, Schanz U, Chalandon Y, Heim D, Güngör T, Stussi G, Nicoloso G,

Baldomero H, Gratwohl A, Tiercy JM. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biol Blood Marrow Transplant. 2012 Apr;18(4):608-16. PMID: 21963878

199. Sureda A, Canals C, Arranz R, Caballero D, Ribera JM, Brune M, Passweg J, Martino R, Valcarcel D, Besalduch J, Duarte R, Leon A, Pascual MJ, Garcia-Noblejas A, Lopez Corral L, Xicoy B, Sierra J, Schmitz N. Allogeneic stem cell transplantation after reduced intensityconditioning in patients with relapsed or refractory Hodgkin'slymphoma. Results of the HDR-ALLO study - a prospectiveclinical trial by the Grupo Espanol de Linfomas/ Trasplante deMedula Osea (GEL/TAMO) and the Lymphoma Working Party ofthe European Group for Blood and Marrow Transplantation. Haematologica. 2012 Feb;97(2):310-7. PMID: 21993674

200. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012 Jun;47(6):770-90.

201. Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano C, Cook G; IMPROVIT Study Group. Collaborators:

27

Abecasis M, Afanasyev B, Akan H, Anagnostopoulos A, Batlle M, Bofarull RM, Bordigoni P, Bourhis JH, Bow E, Cetkovsky P, Cordonnier C, Crawley C, de la Camara R, Eser B, Espigado E, El Hadad E, de la Serna J,Faucher C, Gratwohl A, Haider S, Hunter C, Larverdière M, Leprêtre S, Liakopoulou E, Maschan A, Mayer J, Milpied N, Narayanan S, Parker A, Passweg J, Perez J, Peristeri I, Pimentel P, Potter M, Reman O, Rovira M, Saad M, Sanz M, Smith M, Vazquez L, Wilson K.Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol. 2011 Nov;155(3):318-27. doi: 10.1111/j.1365-2141.2011.08838.x. Epub 2011 Aug 22.

202. Brehm C, Huenecke S, Quaiser A, Esser R, Bremm M, Kloess S, Soerensen J, Kreyenberg

H, Seidl C, Becker PS, Mühl H, Klingebiel T, Bader P, Passweg JR, Schwabe D, Koehl U. IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study. PLoS One. 2011;6(11):e27351. Epub 2011 Nov 9.

203. Calmy A, Bel M, Nguyen A, Combescure C, Delhumeau C, Meier S, Yerly S, Kaiser L, Hirschel B, Siegrist CA; the H1N1 study group. Collaborators: Siegrist CA, Posfay-Barbe K, Meier S, Bel M, Grillet S, Sealy G, Demeules J, Charvat S, Verdon M, Combescure C, Hirschel B, Calmy A, Nguyen A, Delhumeau-Cartier C, Gabay C, Guerne PA, Seebach J, Ribi C,Villard J, Dietrich PY, George AC, Favet L, van Delden C, Morard I, Mentha G, Giostra E, Hadaya K, Martin PY, Soccal P, Berney T, Noble S, Mohty B, Nagy M, Chalandon Y, Roosnek E, Passweg J, Kaiser L, Yerly S,Thomas Y, Wunderli W. Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients. HIV Med. 2011 Nov 7. doi: 10.1111/j.1468-1293.2011.00961.x. [Epub ahead of print]

204. Meyer-Monard S, Tichelli A, Troeger C, Arber C, de Faveri GN, Gratwohl A, Roosnek E, Surbek D, Chalandon Y, Irion O, Castelli D, Passweg J, Kindler V. Initial cord blood unit volume affects mononuclear cell and CD34(+) cell-processing efficiency in a non-linear fashion. Cytotherapy. 2011 Dec 5. [Epub ahead of print]

205. Michael Medinger, Elisabeth Saller, Cornelis L Harteveld, Thomas Lehmann, Lukas Graf,

Alicia Rovo, Andreas Buser, Jakob Passweg, André Tichelli. A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematology Reports 2011; volume 3:e30

206. Ansari M, Strunk D, Schallmoser K, Delcò C, Rougemont AL, Moll S, Villard J, Gumy-Pause F, Chalandon Y, Parvex P, Passweg J, Ozsahin H, Kindler V. Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. Pediatr Transplant. 2011 Dec 7. doi: 10.1111/j.1399-3046.2011.01621.x. [Epub ahead of print]

207. Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuhrer M, Risitano A, Dufour C, Passweg J, Oneto R, Aljurf M, Flynn C, Mialou V, Hamladji RM, Marsh J. Bone marrow versus peripheral blood sibling transplants in acquired aplastic anemia: survival advantage for marrow in all age groups. Haematologica. 2012 Feb 7. [Epub ahead of print] PMID: 22315497

28

208. Battiwalla M, Wang T, Carreras J, Joachim Deeg H, Ayas M, Bajwa RP, George B, Gupta V, Pasquini R, Schrezenmeier H, Passweg JR, Schultz KR, Eapen M. HLA-matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft vs. Host Disease and Overall Survival. Biol Blood Marrow Transplant. 2012 Feb 28. [Epub ahead of print]

209. Ruutu T, van Biezen A, Hertenstein B, Henseler A, Garderet L, Passweg J, Mohty M, Sureda A, Niederwieser D, Gratwohl A, de Witte T. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012 Mar 12. doi: 10.1038/bmt.2012.45. [Epub ahead of print]

210. Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Vekemans MC, Biemond B, Sonneveld P, Passweg J, Verdonck L, Legdeur MC, Theobald M, Jacky E, Bargetzi M, Maertens J, Ossenkoppele GJ, Löwenberg B. Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose-escalation of cytarabine. Blood. 2012 Mar 15. [Epub ahead of print]

211. Nebiker CA, Lardinois D, Junker L, Gambazzi F, Matt P, Habicht J, Halter J, Heim D, Stern M, Buser AS, Passweg J, Stolz D, Flückiger UM, Weisser M, Battegay M, Bubendorf L, Gratwohl A, Tamm M. LUNG RESECTION IN HEMATOLOGIC PATIENTS WITH PULMONARY INVASIVE FUNGAL DISEASE. Chest. 2012 Mar 29. [Epub ahead of print]

212. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, Witte TD, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; for the European Group for Blood and Marrow Transplantation (EBMT). The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012 Apr 30. doi: 10.1038/bmt.2012.66. [Epub ahead of print] PMID: 22543746

213. Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, Killick SB, Warren AJ, Foukaneli T, Aljurf M, Al-Zahrani HA, Schafhausen P, Roth A, Franzke A, Brummendorf TH, Dufour C, Oneto R, Sedgwick P, Barrois A, Kordasti S, Elebute MO, Mufti GJ, Socie G. Prospective study of rabbit antithymocyte globulin and ciclosporin for aplastic anemia from the EBMT Severe Aplastic Anemia Working Party. Blood. 2012 Jun 7;119(23):5391-6. PMID: 22544699

214. Cornelissen JJ, Breems D, van Putten WL, Gratwohl AA, Passweg JR, Pabst T, Maertens J, Beverloo HB, van Marwijk Kooy M, Wijermans PW, Biemond BJ, Vellenga E, Verdonck LF, Ossenkoppele GJ, Löwenberg B.Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories. J Clin Oncol. 2012 Jun 10;30(17):2140-6.

215. Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz

MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S,Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Collaborators: Christiansen F, Gervais T, Emonds MP, Pereira N, Pasquini R, Schroeder ML, Jindra P, Venigova P, Koza V, Absi L, Valerie D, Raus N, Bignon JD,Gagne K, Jollet I, Derin R, Charron D, Loiseau P, Raffoux C, Marry E, Gluckman E, Socié G,

29

Masson D, DeMatteis M, Dormoy A, Picard C, Basire A,Frassati C, Bornhauser M, Ehninger G, Füssel M, Adorno D, Di Bartolomeo P, Martinetti M, Pasi A, Alessandrino EP, Nesci S, Visani G, Morishima Y,Oudshoorn M, Cornelissen JJ, van Biezen A, Spierings E, Egeland T, Vaage JT, Brinch L, DuToit E, Jacobs P, Wood L, Bengtsson M, Schaffer M,Ringdén O, Tiercy JM, Chalandon Y, Passweg J, Stern M, Gratwohl A, Schanz U, Lee TD, Madrigal A, Marsh S, Shaw B, Frater A, Clarke B, Cook G,Spellman S, Haagenson M, Petersdorf E, Malkki M, Schoch G, Gooley T, Senitzer D, Velardi A, de Elvira CR, Horowitz M, Klein J, Wang T, Lee S, Nolan A, Madrigal A, Marsh S, Nolan A, Raus N, Cornelissen JJ, den Hoed D, van Biezen A, Morishima Y. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol. 2012 Apr;13(4):366-74. Epub 2012 Feb 15.

216. Medinger M, Saller E, Harteveld CL, Lehmann T, Graf L, Rovo A, Buser A, Passweg J, Tichelli A. A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematol Rep. 2011 Oct 19;3(3):e30. Epub 2011 Dec 6. PMID: 22593821

217. Mounier N, Canals C, Gisselbrecht C, Cornelissen J, Foa R, Conde E, Maertens J, Attal M,

Rambaldi A, Crawley C, Luan JJ, Brune M, Wittnebel S, Cook G, van Imhoff GW, Pfreundschuh M, Sureda A; Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT). Collaborators: Gisselbrecht C, Cornelissen JJ, Foa R, Conde E, Maertens J, Attal M, Rambaldi A, Crawley C, Brune M, Cook G, van Imhoff GW, Pfreundschuh M,Castagna L, Russell NH, Colombat P, Richardson D, Polreicht D, Tilly H, Sutton L, Carreras E, Blaise D, McQuaker G, Peniket A, Gramatzki M,Milpied N, Jouet JP, Cortelazzo S, Bosi A, Irrera G, Janssen J, Passweg J, Bacigalupo A, Schattenberg A, Mohty M, Cortelezzi A, Bay JO, Lenhoff S, Volin L, Cassuto JP, Duarte RF, Gribben J, Michieli M, Veelken JH, Poire X, Petersen E, Baccarani M, McMullin MF, Jantunen E, Wijermans PW,Schouten H, Wandt H, Bourjuis JH, Caballero D, Martelli MF, Bron D, Biron P, Sureda A, Bazarbachi A, Craddock C, Masszi T, Bailly B, Thompson K, Alegre A, Blesing NE, Nagler A, Hall R, Sengeloev H, Deconinck E, Guilhot F, Ifrah N, De Revel T, Koza V, Besalduch J. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant. 2012 May;18(5):788-93. Epub 2011 Oct 17.

218. Peffault de Latour R, Schrezenmeier H, Bacigalupo A, Blaise D, de Souza CA, Vigouroux S, Willemze R, Terriou L, Tichelli A, Mohty M, de Guibert S, Marsh J, Passweg J, Mary JY, Socie G. Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria. Haematologica. 2012 Jun 11. [Epub ahead of print]

219. Martin I, Baldomero H, Bocelli-Tyndall C, Passweg J, Saris D, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue Eng Part A. 2012 Jun 12. [Epub ahead of print]

220. Schäppi MG, Meier S, Bel M, Siegrist CA, Posfay-Barbe KM; H1N1 Study Group. Collaborators (42) Siegrist CA, Posfay-Barbe K, Meier S, Bel M, Grillet S, Sealy G, Demeules J, Charvat S, Verdon M, Combescure C, Hirschel B, Calmy A, Nguyen A, Delhumeau-Cartier C, Ambrosioni J, Gabay C, Guerne PA, Seebach J, Ribi C, Villard J, Dietrich PY, George AC, Favet L, van Delden C, Morard I,Mentha G, Giostra E, Hadaya K, Martin PY, Soccal P,

30

Berney T, Noble S, Mohty B, Nagy M, Chalandon Y, Roosnek E, Passweg J, Kaiser L, Yerly S, Thomas Y, Wunderli W, Belli D. Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease. J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):817-9.

221. Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS. Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2012 Jul 31. [Epub ahead of print]

222. O'Meara A, Halter J, Heim D, Gerull S, Bucher C, Passweg J, Buser A, Stern M. Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI. Biol Blood Marrow Transplant. 2012 Aug 13. [Epub ahead of print]

223. Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter AE, Kim TS, Socie G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Ongoing graft-versus-host disease is a risk factor for azoospermia afterallogeneic hematopoietic stem cell transplantation. A survey of the late effect working party of the European Group for Blood and Marrow Transplantation. Haematologica. 2012 Aug 28. [Epub ahead of print]

224. Gerull S, Stern M, Ben Aissa A, Manz MG, Schanz U, Stussi G, Chalandon Y, Passweg J, Mohty B. Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT. Bone Marrow Transplant. 2012 Sep 3. doi: 10.1038/bmt.2012.167. [Epub ahead of print] PMID: 22941381

225. Stern M, Passweg JR, Meyer-Monard S, Esser R, Tonn T, Soerensen J, Paulussen M, Gratwohl A, Klingebiel T, Bader P, Tichelli A, Schwabe D, Koehl U. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant. 2012 Sep 3. doi: 10.1038/bmt.2012.162. [Epub ahead of print] PMID:22941380

226. Girsberger S, Karow A, Lundberg P, Dirnhofer S, Lehmann T, Passweg JR, Tichelli A, Skoda R, Rovó A. JAK2 V617F-Mutated Myeloproliferative Neoplasia Developing Five Years after Wild-Type JAK2 Acute Myeloid Leukemia: A Case Report. Acta Haematol. 2012 Sep 18;129(1):23-25. [Epub ahead of print]

227. Siegrist CA, van Delden C, Bel M, Combescure C, Delhumeau C, Cavassini M, Clerc O, Meier S, Hadaya K, Soccal PM, Yerly S, Kaiser L, Hirschel B, Calmy A;H1N1 Study Group; Swiss HIV Cohort Study (SHCS). Collaborators (92): Siegrist CA, Posfay-Barbe K, Meier S, Bel M, Grillet S, Sealy G, Demeules J, Charvat S, Verdon M, Combescure C, Hirschel B, Calmy A, Delhumeau-Cartier C, Gabay C, Guerne PA, Seebach J, Ribi C, Villard J, Dietrich PY, George AC, Favet L, van Delden C, Morard I, Mentha G, Giostra E, Hadaya K, Martin PY, Soccal P, Berney T, Noble S, Mohty B, Nagy M, Chalandon Y, Roosnek E, Passweg J, Kaiser L, Yerly S, Thomas Y, Wunderli W, Barth J,Battegay M, Bernasconi E, Böni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Cellerai C, Egger M, Elzi L, Fehr J, Fellay J,

31

Flepp M,Francioli P, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hirschel B, Hösli I, Kahlert C, Kaiser L, Keiser O, Kind C,Klimkait T, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Nadal D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schmid P, Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S. Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine. PLoS One. 2012;7(7):e40428. Epub 2012 Jul 27.

228. Meinke R, Meyer B, Frei R, Passweg J, Widmer AF. Equal efficacy of glucoprotamin and an aldehyde product for environmental disinfection in a hematologic transplant unit: a prospective crossover trial. Infect Control Hosp Epidemiol. 2012 Nov;33(11):1077-80. doi: 10.1086/668028. Epub 2012 Sep 21.

229. Ossenkoppele GJ, Stussi G, Maertens J, van Montfort K, Biemond BJ, Breems DM, Ferrant A, Graux C, de Greef GE, Halkes CJ, Hoogendoorn M, Hollestein RM, Jongen-Lavrencic M, Levin MD, van de Loosdrecht AA, van Marwijk Kooij M, van Norden Y, Pabst T, Schouten HC, Vellenga E, Verhoef GE, de Weerdt O, Wijermans P, Passweg JR, Lowenberg B. Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase II trial of HOVON/SAKK. Blood. 2012 Oct 9. [Epub ahead of print]

230. Siegrist CA, Ambrosioni J, Bel M, Combescure C, Hadaya K, Martin PY, Soccal PM, Berney T, Noble S, Meier S, Posfay-Barbe K, Grillet S, Kaiser L, van Delden C; H1N1 study group. Collaborators (41): Siegrist CA, Posfay-Barbe K, Meier S, Bel M, Grillet S, Sealy G, Demeules J, Charvat S, Verdon M, Combescure C, Hirschel B, Calmy A, Nguyen A,Delhumeau-Cartier C, Gabay C, Guerne PA, Seebach J, Ribi C, Vilalrd J, Dietrich PY, George AC, Favet L, van Delden C, Ambrosioni J, Morard I,Mentha G, Berney T, Giostra E, Hadaya K, Martin PY, Soccal PM, Noble S, Mohty B, Nagy M, Chalandon Y, Roosnek E, Passweg J, Kaiser L, Yerly S,Thomas Y, Wunderli W. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther. 2012;17(5):893-903. doi: 10.3851/IMP2103. Epub 2012 Apr 27.

231. Medinger M, Tichelli A, Bucher C, Halter J, Dirnhofer S, Rovo A, Passweg J, Tzankov A. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM. Bone Marrow Transplant. 2012 Oct 22. doi: 10.1038/bmt.2012.200. [Epub ahead of print] PMID: 23085826

232. Meyer SC, O'Meara A, Buser AS, Tichelli A, Passweg JR, Stern M. Prognostic Impact of Post-Transplant Iron Overload After Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2012 Oct 19. pii: S1083-8791(12)00428-4. doi: 10.1016/j.bbmt.2012.10.012. [Epub ahead of print]

233. Bucher CM, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A. Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial. J Clin Pathol. 2012 Oct 26. [Epub ahead of print]

234. Sigle JP, Infanti L, Studt JD, Martinez M, Stern M, Gratwohl A, Passweg J, Tichelli A, Buser AS. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet

32

components and gamma-irradiated platelet components. Transfusion. 2012 Nov 26. doi: 10.1111/j.1537-2995.2012.03959.x. [Epub ahead of print]

235. Finke J, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E,Koza V, Bornhäuser M, Einsele H, Bertz H, Grishina O, Socié G; ATG-Fresenius Trial Group. Collaborators (104) Finke J, Schneeberger H, Petan J, Kainz A, Schmoor C, Grishina O, Schilling B, Kaufmann M, Tostmann R, Kollmer A, Nuss S, Wenig C, Bertz H, Egger M, Zander AR, Wolschke C, Schwerdtfeger R, Kolbe K, Thomas S, Ullmann A, Schulze-Bergkamen A, Hahn J, Bornhäuser M, Schaefer-Eckart K,Gluckman E, Esperou H, Robin M, Michallet M, Nicolini F, Buzyn A, Rubio MT, Clement L, Salmon A, Feugier P, Ruutu T, Volin L, Juvonen E, Nihtinen A, Remes K, Putkonen M, Voglova J, Lebavy J, Zak P, Heim D, Gratwohl A, Passweg J, Arber C, Tsakiris A, Linkesch W, Reitter S, Lutz D, Maertens A,Theunissen K, Boogaerts M, Verhoef G, Rowe J, Rosenvald-Zuckermann T, Shapira M, Resnik I, Nagler A, Shimoni A, Yerushalmi R, Sierra J, Valcarcel D, Astorga M, Bosi A, Börner G, Gamperl HJ, Jauch J, Müller Ch, Scheele J, Bethge WA, Einsele H, Müller RF, Häntschel M, Ottinger HD, Stelljes M,Kröger NM, Ayuketang FA, Kaltenhäuser J, Stübig T, Taube RH, Holler E, Kolb HJ, Reibke R, Wandt H, Socié G, Yakoub-Agha I, Jouet JP, Petillon MO,Bordigoni P, Itälä M, Kauppila M, Mayer J, Krejci M, Brychtová Y, Koza V, Karas M, Staber PB, Krieger O, Or R, Pérez Simón JA, Astorga M, Guidi S. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Transplant. 2012 Nov;18(11):1716-26. doi: 10.1016/j.bbmt.2012.06.001. Epub 2012 Jun 17.

236. Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A Study of the late effects working party of the EBMT.Bone Marrow Transplant. 2013 Jan 7. doi: 10.1038/bmt.2012.255. [Epub ahead of print] No abstract available. PMID: 23292242 [PubMed - as supplied by publisher]

237. Holbro A, Jotterand M, Passweg JR, Buser A, Tichelli A, Rovó A. Favorable long-term outcome of patients with 13q deletion and aplastic anemia. Haematologica. 2013 Jan 8. [Epub ahead of print] PMID:23300181 [PubMed - as supplied by publisher]

238. Labarinas S, Gumy-Pause F, Rougemont AL, Baerlocher G, Leibundgut EO, Porret N, Schäppi MG, Barazzone-Argiroffo C, Passweg J, Merlini L, Ozsahin H, Ansari M. Is Acute Fibrinous and Organizing Pneumonia the Expression of Immune Dysregulation? J Pediatr Hematol Oncol. 2013 Jan 17. [Epub ahead of print]

239. Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, Breguet R, Lanthier N, Farina A, Passweg J, Becker CD, Hadengue A. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013;8(1):e53719. doi: 10.1371/journal.pone.0053719. Epub 2013 Jan 14.

240. Passweg J, Baldomero H, Bargetzi M, Bucher C, Chalandon Y, Duchosal MA, Gratwohl

A, Güngör T, Hess U, Leibundgut K, Nicoloso de Faveri G, Ozsahin H, Pabst T, Renner C, Stern M, Stussi G, Schanz U, For the SBST (Swiss Blood Stem Cell Transplantation)

33

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Med Wkly. 2013 Feb 22;143:0. doi: 10.4414/smw.2013.13757.

241. Gratwohl A, Baldomero H, Gratwohl M, Aljurf MD, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica. 2013 Mar 18. [Epub ahead of print] PMID: 23508009

242. Tichelli A, Labopin M, Rovó A, Badoglio M, Arat M, van Lint MT, Lawitschka A, Schwarze CP, Passweg J, Socié G. Increase of suicide and accidental death after hematopoietic stem cell transplantation: A cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer. 2013 Mar 19. doi: 10.1002/cncr.27987. [Epub ahead of print]

243. Passweg JR, Pabst T, Blum S, Bargetzi M, Li Q, Heim D, Stussi G, Gregor M, Leoncini L, Meyer-Monard S, Brauchli P, Chalandon Y; on behalf of the Swiss Group for Clinical Cancer Research (SAKK). Azacytidine for acute myeloid leukemia in elderly or frail patients: A phase II trial (SAKK 30/07). Leuk Lymphoma. 2013 Apr 2. [Epub ahead of print]

244. Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg JR, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter JP, Tamm M. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013 Apr 2. doi:pii: S1083-8791(13)00143-2. 10.1016/j.bbmt.2013.03.017. [Epub ahead of print] PMID: 23562737 [PubMed - as supplied by publisher]

245. Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Kröger N, Farge-Bancel D, Bobby Gaspar H, Marsh J, Mohty M, Peters C, Sureda A, Velardi A, Ruiz de Elvira C, Madrigal A. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant. 2013 Apr 15. doi: 10.1038/bmt.2013.51. [Epub ahead of print] PMID: 23584439 [PubMed - as supplied by publisher]

246. Bart T, Boo M, Balabanova S, Fischer Y, Nicoloso G, Foeken L, Oudshoorn M, Passweg J, Tichelli A, Kindler V, Kurtzberg J, Price T, Regan D, Shpall EJ, Schwabe R. Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations. Transfus Med Hemother. 2013 Feb;40(1):14-20. doi: 10.1159/000345690. Epub 2013 Jan 7. PMID: 23637645

247. Koehl U, Brehm C, Huenecke S, Zimmermann SY, Kloess S, Bremm M, Ullrich E, Soerensen J, Quaiser A, Erben S, Wunram C, Gardlowski T, Auth E, Tonn T, Seidl C, Meyer-Monard S, Stern M, Passweg J, Klingebiel T, Bader P, Schwabe D, Esser R. Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol. Front Oncol. 2013 May 17;3:118. doi: 10.3389/fonc.2013.00118. Print 2013. PMID: 23730623

248. Maury S, Balère-Appert ML, Pollichieni S, Oneto R, Yakoub-Agha I, Locatelli F, Dalle JH, Lanino E, Fischer A, Pession A, Huynh A, Barberi W, Mohty M, Risitano A, Milpied N, Socié G, Bacigalupo A, Marsh J, Passweg JR. Outcome of patients activating an unrelated

34

donor search for severe acquired aplastic anemia. Am J Hematol. 2013 Jun 27. doi: 10.1002/ajh.23522. [Epub ahead of print] PMID: 23804195

249. Girsberger S, Wehmeier C, Amico P, Dirnhofer S, Marti E, Halter JP, Passweg JR, Bucher CM. Donor-derived acute myeloid leukemia in a kidney transplant recipient. Blood. 2013 Jul 11;122(2):298-300.

250. Schlenk RF, Taskesen E, van Norden Y, Krauter J, Ganser A, Bullinger L, Gaidzik VI, Paschka P, Corbacioglu A, Göhring G, Kündgen A, Held G, Götze K, Vellenga E, Kuball J, Schanz U, Passweg J, Pabst T, Maertens J, Ossenkoppele GJ, Delwel R, Döhner H, Cornelissen JJ, Döhner K, Löwenberg B. The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood. 2013 Jul 17. [Epub ahead of print] PMID: 23863898

251. Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V, Melamed M,

Kristt DA, Steinberg A, Shulman C, Hwang P, Koren G, Walfisch A, Passweg JR, Snowden JA, Tamouza R, Leboyer M, Farge-Bancel D, Ashwood P. Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun. 2013 Jul 15. doi:pii: S0896-8411(13)00073-5. 10.1016/j.jaut.2013.05.005. [Epub ahead of print]

252. Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socie' G, Tischer J, Oneto R, Passweg J, Marsh J. Syngeneic transplantation in aplastic anemia: pretransplant conditioning and peripheral blood are associated with improved engraftment - an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Jul 26. [Epub ahead of print]

253. Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, Garderet L, Greinix H, Holler E, Kröger N, Lawitschka A, Mohty M, Nagler A, Passweg J, Ringdén O, Socié G, Sierra J, Sureda A, Wiktor-Jedrzejczak W, Madrigal A, Niederwieser D. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant. 2013 Jul 29. doi: 10.1038/bmt.2013.107. [Epub ahead of print] PMID: 23892326

254. Mueller SM, Haeusermann P, Rovó A, Halter JP, Passweg J, Itin P, Tichelli A. Genital chronic GVHD in males after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients. Biol Blood Marrow Transplant. 2013 Aug 17. doi:pii: S1083-8791(13)00312-1. 10.1016/j.bbmt.2013.07.010. [Epub ahead of print]

255. Nagler A, Rocha V, Labopin M, Unal A, Ben Othman T, Campos A, Volin L, Poire X, Aljurf M, Masszi T, Socie G, Sengelov H, Michallet M, Passweg J, Veelken H, Yakoub-Agha I, Shimoni A, Mohty M. Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen--A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2013 Aug 26. [Epub ahead of print]

35

256. Lanza F, Campioni D, Hellmann A, Milone G, Wahlin A, Walewski J, Fiamenghi C, Spedini P, Knopińska W, Swierkowska-Czeneszew M, Petriz J, Fruehauf S, Farge D, Mohty M, Passweg J, Ruuto T, Madrigal A, Johnsen H. Individual Quality Assessment Of Autografting By Probability Estimation For Clinical End-Points: A Prospective Validation Study Of The European Blood And Marrow Transplantation (Ebmt). Biol Blood Marrow Transplant. 2013 Aug 26. doi:pii: S1083-8791(13)00382-0. 10.1016/j.bbmt.2013.08.005. [Epub ahead of print] PMID: 23988403

257. Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Collaborators: Fischer G, Mayr W, Schroeder ML, Ellison C, Kwan L, Jindra P, Venigova P, Absi L, Dubois V, Cesbron A, Gagne K, Jollet I, Masson D, DeMatteis M, Bernard G, Hanau D, Parissiadis A, Bornhauser M, Ehninger G, Füssel M, Canossi A, Aureli A, Morishima Y, Kawase T, Egeland T, Vaage JT, Brinch L, DuToit E, Jacobs P, Wood L, Bengtsson M, Schaffer M, Ringdén O, Tiercy JM, Chalandon Y, Passweg J, Stern M, Gratwohl A, Schanz U, Güngör T, Frater A, Clarke B, Cook G, Petersdorf E, Malkki M, Schoch G, Gooley T, Hsu K, Senitzer D, Gendzekhadze K. Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6.

258. Marek A, Stern M, Chalandon Y, Ansari M, Ozsahin H, Güngör T, Gerber B, Kühne T, Passweg JR, Gratwohl A, Tichelli A, Seger R, Schanz U, Halter J, Stussi G. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplant. 2013 Sep 16. doi: 10.1038/bmt.2013.132. [Epub ahead of print] PMID: 24037023

259. Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ. High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study. J Clin Oncol. 2013 Sep 23. [Epub ahead of print]

260. Meyer SC, Medinger M, Halter JP, Baldomero H, Hirsch HH, Tzankov A, Dirnhofer S, Passweg JR, Tichelli A. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. Hematology. 2013 Sep 12. [Epub ahead of print] PMID: 24074746

261. Martin I, Baldomero H, Bocelli-Tyndall C, Emmert M, Hoerstrup SP, Ireland H, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A. 2013 Oct 3. [Epub ahead of print] PMID: 24090467

262. Gratwohl A, Baldomero H, Passweg J. Hematopoietic stem cell transplantation activity in Europe. Curr Opin Hematol. 2013 Nov;20(6):485-493. PMID: 24104408

36

263. Bürgler D, Medinger M, Passweg J, Fischmann A, Bucher C. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD. Leuk Res. 2013 Nov 5. doi:pii: S0145-2126(13)00382-2. 10.1016/j.leukres.2013.10.024. [Epub ahead of print] PMID: 24268317

264. Holbro A, Graf L, Topalidou M, Bucher C, Passweg JR, Tsakiris DA. Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment. Transfusion. 2013 Dec 4. doi: 10.1111/trf.12511. [Epub ahead of print] PMID: 24304039

265. Medinger M, Muesser P, Girsberger S, Skoda R, Tzankov A, Buser A, Passweg J, Tsakiris D. Dkk3 levels in patients with myeloproliferative neoplasms. Thromb Res. 2013 Nov 14. doi:pii: S0049-3848(13)00521-5. 10.1016/j.thromres.2013.11.003. [Epub ahead of print] PMID: 24309205

266. Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, Garderet L, Greinix H, Holler E, Kröger N, Lawitschka A, Mohty M, Nagler A, Passweg J, Ringdén O, Socié G, Sierra J, Sureda A, Wiktor-Jedrzejczak W, Madrigal A, Niederwieser D. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant. 2013 Dec 23. doi: 10.1038/bmt.2013.210. [Epub ahead of print] PMID: 24362365

267. Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 2014 Jan 29. [Epub ahead of print] PMID: 24478400

268. Avivi I, Canals C, Vernant JP, Wulf G, Nagler A, Hermine O, Petersen E, Yakoub-Agha I,

Craddock C, Schattenberg A, Niederwieser D, Thomson K, Blaise D, Attal M, Pfreundschuh M, Passweg J, Russell N, Dreger P, Sureda A. Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma. Bone Marrow Transplant. 2014 Feb 10. doi: 10.1038/bmt.2014.4. [Epub ahead of print] PMID: 24510071

269. O'Meara A, Holbro A, Meyer S, Martinez M, Medinger M, Buser A, Halter J, Heim D, Gerull S, Bucher C, Rovo A, Kuehne T, Tichelli A, Gratwohl A, Stern M, Passweg J. Forty years of haematopoietic stem cell transplantation: a review of the Basel experience. Swiss Med Wkly. 2014 Feb 24;144:w13928. doi: 10.4414/smw.2014.13928. PMID: 24567259

270. Rueff J, Medinger M, Heim D, Passweg J, Stern M. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biol Blood Marrow Transplant. 2014 Mar 13. pii: S1083-8791(14)00156-6. doi: 10.1016/j.bbmt.2014.03.007. [Epub ahead of print] PMID: 24631739

271. Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant. 2014 Mar 17. doi: 10.1038/bmt.2014.55. [Epub ahead of print] PMID: 24637898

37

272. Manegold-Brauer G, Borner B, Bucher C, Hoesli I, Passweg J, Girsberger S, Schoetzau A, Gisin S, Visca E. A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking. Transfusion. 2014 Apr 28. PMID: 24773337

273. Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM. Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Bone Marrow Transplant. 2014 Apr 28. PMID: 24777183

274. Brehm C, Huenecke S, Esser R, Kloess S, Quaiser A, Betz S, Zimmermann O, Soerensen J, Passweg JR, Klingebiel T, Schwabe D, Bader P, Koehl U. Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy. Cancer Immunol Immunother. 2014 May 8. [Epub ahead of print]

275. Hussein AA, Halkes CM, Socié G, Tichelli A, Borne PA, Schaap MN, Foa R, Ganser A, Dufour C, Bacigalupo A, Locasciulli A, Aljurf M, Peters C, Robin M, van Biezen AA, Volin L, De Witte T, Marsh J, Passweg JR, Kröger N; severe aplastic anemia and chronic malignancies working parties of the European Group for Blood and Marrow Transplantation (EBMT). Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA) of the EBMT. Biol Blood Marrow Transplant. 2014 Jun 5. pii: S1083-8791(14)00328-0. doi: 10.1016/j.bbmt.2014.05.028. [Epub ahead of print] PMID: 24910382

276. Robin M, Giannotti F, Deconinck E, Mohty M, Michallet M, Sanz G, Chevallier P, Cahn

JY, Legrand F, Rovira M, Passweg J, Sierra J, Nguyen S, Maillard N, Yakoub-Agha I, Linkesch W, Cannell P, Marcatti M, Bay JO, Chalandon Y, Kröger N, Gluckman E, Rocha V, Olavarria E, Ruggeri A; Eurocord and CMWP-EBMT. Unrelated Cord Blood Transplantation for patients with Primary or Secondary Myelofibrosis. Biol Blood Marrow Transplant. 2014 Jun 16. pii: S1083-8791(14)00361-9. doi: 10.1016/j.bbmt.2014.06.011. [Epub ahead of print] PMID: 24946719

277. Gerull S, Medinger M, Heim D, Passweg J, Stern M. Evaluation of the Pre-Transplantation Workup Before Allogeneic Transplantation. Biol Blood Marrow Transplant. 2014 Jun 27. pii: S1083-8791(14)00396-6. doi: 10.1016/j.bbmt.2014.06.029. [Epub ahead of print] PMID: 24979730

278. Holbro A, Stern M, Infanti L, O'Meara A, Drexler B, Frey BM, Tiercy JM, Passweg JR, Gassner C, Buser A, Sigle JP. Impact of recipient ABH secretor status on outcome in minor ABO-incompatible hematopoietic stem cell transplantation. Transfusion. 2014 Jul 2. doi: 10.1111/trf.12768. [Epub ahead of print] PMID: 24990435

279. Chalandon Y, Passweg JR, Guglielmi C, Iacobelli S, Apperley J, Schaap NP, Finke J, Robin M, Fedele R, Bron D, Yakoub-Agha I, van Biezen A, de Witte T, Kröger N, Olavarria E. Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic

38

Malignancies Working Party of the EBMT. Haematologica. 2014 Jul 4. pii: haematol.2013.100198. [Epub ahead of print] PMID: 24997146

280. Affolter K, Tamm M, Jahn K, Halter J, Passweg J, Hirsch HH, Stolz D. Galactomannan in

the Bronchoalveolar Lavage for Diagnosing Invasive Fungal Disease. Am J Respir Crit Care Med. 2014 Jul 9. [Epub ahead of print] PMID: 25007380

281. Dufour C, Pillon M, Passweg J, Socié G, Bacigalupo A, Franceschetto G, Carraro E, Oneto R, Risitano AM, Peffault de Latour R, Tichelli A, Rovo A, Peters C, Hoechsmann B, Samarasinghe S, Kulasekararaj AG, Schrezenmeier H, Aljurf M, Marsh J. Outcome of Aplastic Anemia in adolescence. A survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2014 Aug 1. pii: haematol.2014.106096. [Epub ahead of print] PMID: 25085353

282. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NM, Waltimo T, Passweg JR, Correa ME, Dahllöf G, Garming-Legert KU, Logan RM, Potting CM, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SB. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2014 Sep 5. [Epub ahead of print]

283. Grossman P, Zwahlen D, Halter JP, Passweg JR, Steiner C, Kiss A. A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings. Support Care Cancer. 2014 Oct 10. [Epub ahead of print] PMID: 25297466

284. Stuehler C, Nowakowska J, Bernardini C, Topp MS, Battegay M, Passweg J, Khanna N. Multi-specific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. J Infect Dis. 2014 Nov 2. pii: jiu607. [Epub ahead of print]

285. Vuichard D, Weisser M, Orasch C, Frei R, Heim D, Passweg JR, Widmer AF. Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis. BMC Infect Dis. 2014 Nov 11;14(1):573.

286. Martin I, Ireland H, Baldomero H, Passweg J. The survey on cellular and engineered tissue therapies in Europe in 2012. Tissue Eng Part A. 2014 Nov 25. [Epub ahead of print] PMID: 25425342

287. Cornelissen JJ, Versluis J, Passweg JR, van Putten WL, Manz MG, Maertens J, Beverloo

HB, Valk PJ, van Marwijk Kooy M, Wijermans PW, Schaafsma MR, Biemond BJ, Vekemans MC, Breems DA, Verdonck LF, Fey MF, Jongen-Lavrencic M, Janssen JJ, Huls G, Kuball J, Pabst T, Graux C, Schouten HC, Gratwohl A, Vellenga E, Ossenkoppele G, Löwenberg B. Comparative therapeutic value of post remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia. 2014 Nov 27. doi: 10.1038/leu.2014.332. [Epub ahead of print] PMID: 25428261

39

288. Schäfer C, O'Meara A, Tsakiris DA, Medinger M, Passweg JR, Stern M.Influence of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients with Severe Thrombocytopenia after Chemotherapy: A Retrospective Study. Acta Haematol. 2014 Dec 2;133(3):317-320.

289. Koenecke C, Göhring G, de Wreede LC, van Biezen A, Scheid C, Volin L, Maertens J, Finke J, Schaap N, Robin M, Passweg J, Cornelissen J, Beelen D, Heuser M, de Witte T, Kröger N. Impact of the revised International Prognostic Scoring System cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Haematologica. 2014 Dec 31. pii: haematol.2014.116715. [Epub ahead of print] PMID: 25552702

290. Bacigalupo A, Socié G, Hamladji RM, Aljurf M, Maschan A, Kyrcz-Krzemien S, Cybicka

A, Sengelov H, Unal A, Beelen D, Locasciulli A, Dufour C, Passweg JR, Oneto R, Signori A, Marsh JC. Current outcome of HLA identical sibling vs. unrelated donor transplants in severe aplastic anemia: an EBMT analysis. Haematologica. 2015 Jan 23. pii: haematol.2014.115345. [Epub ahead of print] PMID: 25616576

291. Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant. 2015 Feb 2. [Epub ahead of print] PMID: 25642761

292. Medinger M, Halter J, Heim D, Buser A, Gerull S, Stern M, Passweg J. Angiogenic markers in plasma cell myeloma patients treated with novel agents. Anticancer Res. 2015 Feb;35(2):1085-90

293. Sidler JA, Frei R, Tschudin-Sutter S, Dangel M, Battegay M, Weisser M, Passweg J,

Widmer AF. Is admission screening for Pseudomonas aeruginosa useful in haematological patients: a prospective study with 1310 patients. Clin Microbiol Infect. 2015 Feb 10. pii: S1198-743X(15)00291-8. doi: 10.1016/j.cmi.2015.02.004. [Epub ahead of print] PMID: 25680312

294. Dufour C, Pillon M, Sociè G, Rovò A, Carraro E, Bacigalupo A, Oneto R, Passweg J,

Risitano A, Tichelli A, Peffault de Latour R, Schrezenmeier H, Hocshmann B, Peters C, Kulasekararaj A, Van Biezen A, Samarasinghe S, Hussein AA, Ayas M, Aljurf M, Marsh J. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol. 2015 Feb 14. doi: 10.1111/bjh.13297. [Epub ahead of print] PMID: 25683884

295. Eggimann L, Girsberger S, Halter J, Gerull S, Tichelli A, Baldomero H, Heim D, Passweg

J, Rovó A. Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT. Bone Marrow Transplant. 2015 Mar 2. doi: 10.1038/bmt.2015.3. [Epub ahead of print] No abstract available. PMID: 5730193

40

296. Stuehler C, Kuenzli E, Jaeger VK, Baettig V, Ferracin F, Rajacic Z, Kaiser D, Bernardini C, Forrer P, Weisser M, Elzi L, Battegay M, Halter J, Passweg J, Khanna N. Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis. J Infect Dis. 2015 Mar 6. pii: jiv143. [Epub ahead of print] PMID: 25748323

297. Matthes T, McKee T, Dunand-Sauthier I, Manfroi B, Park S, Passweg J, Huard B. Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow. Leukemia. 2015 Mar 10. doi: 10.1038/leu.2015.68. [Epub ahead of print] PMID: 25753925

298. Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T. Erythropoietin receptor mutation-a rush of blood to the head? Ann Hematol. 2015 Mar 14. [Epub ahead of print] No abstract available. PMID: 25772631

299. Sahebi F, Iacobelli S, Biezen AV, Volin L, Dreger P, Michallet M, Ljungman PT, de Witte T, Henseler A, Schaap NP, López-Corral L, Poire X, Passweg J, Hamljadi RM, Thomas SH, Schonland S, Gahrton G, Morris C, KrÖger N, Garderet L. Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma. Bone Marrow Transplant. 2015 Mar 23. doi: 10.1038/bmt.2015.45. [Epub ahead of print] PMID: 25798673

300. Gratwohl A, Baldomero H, Passweg J. The role of hematopoietic stem cell transplantation in chronic myeloid leukemia. Ann Hematol. 2015 Apr;94(Supplement 2):177-186. Epub 2015 Mar 27. PMID: 25814084

301. Paiano S, Roosnek E, Tirefort Y, Nagy-Hulliger M, Masouridi S, Levrat E, Bernimoulin M, Huguet S, Casini A, Matthes T, Samii K, Passweg JR, Chalandon Y. Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies. Bone Marrow Res. 2015;2015:980924. doi: 10.1155/2015/980924. Epub 2015 Mar 22. PMID: 25874131

302. Rothenbuehler SP, Palmowski-Wolfe AM, Passweg JR, Hollbach N. [Bilateral Optic Disc

Swelling, Vitreous Haemorrhage and Roth's Spots in Chronic Myeloid Leukemia]. Klin Monbl Augenheilkd. 2015 Apr;232(4):564-565.

303. Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study (STCS); Collaborators: Achermann R, Aubert JD, Baumann P, Beldi G, Benden C, Berger C, Binet I, Bochud PY, Boely E, Bucher H, Bühler L, Carell T, Catana E, Chalandon Y, de Geest S, de Rougemont O, Dickenmann M, Duchosal M, Fehr T, Ferrari-Lacraz S, Garzoni C, Gasche Y, Soccal PG, Giostra E, Golshayan D, Good D, Hadaya K, Hess C, Hillinger S, Hirsch HH, Hofbauer G, Huynh-Do U, Immer F, Klaghofer R, Koller M, Kuntzen T, Laesser B, Lehmann R, Lovis C, Manuel O, Marti HP, Martin PY, Meylan P, Mohacsi P, Morard I, Morel P, Mueller U, Mueller NJ, Mueller-McKenna H, Müller T, Müllhaupt B, Nadal D, Nair G, Pascual M, Passweg J, Ziegler CP, Rick J, Roosnek E, Rosselet A, Rothlin S, Ruschitzka F, Schanz U, Schaub S, Seiler C, Semmo N, Stampf S, Steiger J, Toso C, Tsinalis D, Van Delden C, Venetz JP, Villard J, Wick M, Wilhelm M, Yerly P PTX3 Polymorphisms and Invasive Mold Infections after Solid Organ Transplantation. Clin Infect Dis. 2015 May 14. pii: civ386. [Epub ahead of print]

41

304. Hollenstein Y, Elzi L, Hatz C, Passweg J, Weisser M, Stoeckle M, Halter J, Egli A. Travelling activity and travel-related risks after allogeneic haematopoietic stem cell transplantation - a single centre survey. Swiss Med Wkly. 2015 May 29;145:w14136. doi: 10.4414/smw.2015.14136. eCollection 2015. PMID: 26023908

305. Passweg JR, Labopin M, Cornelissen J, Volin L, Socié G, Huynh A, Tabrizi R, Wu D, Craddock C, Schaap N, Kuball J, Chevallier P, Cahn JY, Blaise D, Ghavamzadeh A, Bilger K, Ciceri F, Schmid C, Giebel S, Nagler A, Mohty M; Acute Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT). Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant. 2015 Jun 1. doi: 10.1038/bmt.2015.121. [Epub ahead of print] PMID: 26030052

306. Passweg JR, Schanz U, Chalandon Y, Güngör T, Baldomero H, Heim D, Nair G, Medinger

M, Masouridi-Levrat S, de Faveri GN, Tiercy JM. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Bone Marrow Transplant. 2015 Jun 8. doi: 10.1038/bmt.2015.129. PMID: 26052916

307. Sigle JP, Holbro A, Lehmann T, Infanti L, Gerull S, Stern M, Tichelli A, Passweg J, Buser

A. Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage. Am J Clin Pathol. 2015 Jul;144(1):145-50

308. Binkert L, Medinger M, Halter JP, Heim D, Gerull S, Holbro A, Lengerke C, Weisser M, Passweg JR. Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation. Bone Marrow Transplant. 2015 Jun 29. doi: 10.1038/bmt.2015.148. [Epub ahead of print] PMID: 26121111

309. Tschan-Plessl A, Halter JP, Heim D, Medinger M, Passweg JR, Gerull S. Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation. Ann Hematol. 2015 Aug 2. [Epub ahead of print] PMID: 26233683

310. Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, Du J, Blazar BR, Arnold R, Kröger N, Passweg J, Halter J, Socié G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multi-center survey. Leukemia. 2015 Jul 31. doi: 10.1038/leu.2015.212. [Epub ahead of print] PMID: 26228813

311. Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, Peffault de Latour R, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulesekararaj A, Marsh JC, Samarasinghe S. Similar outcome of upfront-unrelated and matched sibling stem cell

42

transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol. 2015 Jul 28. doi: 10.1111/bjh.13614. [Epub ahead of print] PMID: 26223288

Book Chapters, Editorials and Reviews 1. Mary M. Horowitz, Jakob R. Passweg, Kathleen A. Sobocinski, Melodee Nugent, John P.

Klein for the Advisory Committee. Bone Marrow Transplantation for Severe Aplastic Anemia. A Report from the International Bone Marrow Transplant Registry. In: Ontogeny of hematopoiesis. Aplastic Anemia. Eds. E. Gluckman, L. Coulombel. Colloque INSERM/John Libbey Eurotext LTD. 1995; Vol 235, pp. 313-317

2. Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ,

Horowitz MM. Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry. In: Clinical Transplants 1994 (Terasaki PI, Cecka JM, eds), UCLA Tissue Typing Laboratory, Los Angeles, California, 1995; pp 87-98.

3. Passweg JR, Rowlings PA, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ,

Horowitz MM. Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry. In: Clinical Transplants 1995 (Cecka JM, Terasaki PI, eds), UCLA Tissue Typing Laboratory, Los Angeles, California, 1996, pp 117-127.

4. Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ,

Horowitz MM. Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR - North America. In: 1996 Yearbook of Cell and Tissue Transplantation (Lanza RP, Chick WL, eds), Kluwer Academic Publishers, 1996, pp 19-34

5. McCann SR, Passweg JR, Storb R, Deeg HJ. HLA-identical sibling bone marrow

transplantation to treat severe aplastic anemia. pp: 230-57. In: Schrezenmeier H, Bacigalupo A (editors) Aplastic Anemia, Pathophysiology and Treatment Cambridge University Press 1999

6. Passweg JR, Gratwohl A, Tyndall A. Hemopoetic Stem Cell Transplantation for

Autoimmune Disorders. Current Opinion in Hematology. 1999; 6:400-405 IF 4.41 7. Jakob R Passweg, Alois Gratwohl, Alan Tyndall. Autologous Hemopoetic Stem Cell

Transplantation for Autoimmune Disease. pp: 123-132, In: P Pozilli, C Pozilli, JF Kapp (editors) New Concepts in Pathology and Treatment of Autoimmune Disorders. Ernst Schering Research Foundation Workshop Supplement 7, Springer press 2001

8. Ashwin Kashyap, Jakob Passweg, Alan Tyndall. Autologous Hematopoietic Stem Cell

Transplant Conditioning Regimens for the Treatment of Severe Autoimmune Diseases; Chapter 4: Autoimmune Disease pp: 219-225, In: Autologous Blood and Marrow Transplantation: Proceedings of the Tenth International Symposium, edited by Karel A. Dicke and Armand Keating, May 2001.

43

9. Gratwohl A, Passweg J, Gerber I, Tyndall A. Stem cell transplantation for autoimmune

diseases. Best Pract Res Clin Haematol. 2001 Dec;14(4):755-76. IF: 3.59 10. H. Schrezenmeier, A.Bacigalupo, J.Passweg , R.Barge, A.Bekassy, M.Führer, J.Hows,

E.Korthof, P.Ljungman, A.Locasciulli, J.Marsh, S.McCann, G.Socie, A.Symeonidis, A.Tichelli, N.Zoumbos for the EBMT Aplastic Anemia Working Party. Aplastic Anaemia. The ESH (European School of Hematology) Handbook 2004

11. Jakob R Passweg. Hematopoetic Stem Cell Transplantation for Immune Thrombopenia and

other Refractory Autoimmune Cytopenias. Best Pract Res Clin Haematol. 2004;17(2):305-15. IF 3.59

12. Jakob R. Passweg, Martin Stern, Ulrike Koehl, Lutz Uharek, André Tichelli. Mini-Review:

The Use of Natural Killer-cells in Hematopoetic Stem Cell Transplantation, Bone Marrow Transplantation 2005 Apr;35(7):637-43. IF 3.0

13. Jakob R Passweg, André Tichelli. Myelodysplastische Syndrome als Leukämie-Vorstufen:

Wann muss man therapeutisch eingreifen? Geriatrie Praxis 2005 16(2):17-23 14. Jakob R. Passweg, Ulrike Koehl, Lutz Uharek, Sandrine Meyer-Monard, André Tichelli

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation Best Practice & Research Clinical Haematology Vol. 19, No. 4, pp. 811-824, 2006 IF 3.59

15. Editorial: H. Moch, JR Passweg: Molekulare Diagnostik/Molekulare Therapie.

Therapeutische Umschau 2006; 62:4 16. Jakob R. Passweg, Bertrand Huard, Jean-Marie Tiercy and Eddy Roosnek HLA and KIR

polymorphisms affect NK-cell anti-tumor activity. Trends in Immunology 2007 Oct;28(10):437-41. IF 9.48

17. Arnold Ganser, Jakob Passweg, Michael Stadler, Christine Dobbelstein, Eva M.Weissinger,

Immunsuppressive Treatment Strategies in Low-Risk MDS. Cancer Treatment Reviews 2007 Sep 27; [Epub ahead of print] IF 4.54

18. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin

Hematol. 2007 Oct;44(4):278-85. IF 3.19 19. A Gratwohl, D. Heim, G. Baerlocher, Y. Chalandon, M. Duchosal, M. Gregor, U. Hess, E.

Oppliger, J. Passweg, U. Schanz, S. Dirnhofer. Behandlung der chronischen myeloischen Leukämie 2007 Empfehlungen der Schweizerischen Arbeitsgruppe CML. Swiss Medical Forum 2007;7:934–940

20. Passweg JR, Chalandon Y, Matthes T, Beris P, Les leucémies aiguës. Rev Med Suisse. 2008

May 21;4(158):1272-4, 1276-8. 21. Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, Passweg J, Roosnek E.

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008 Oct 24. [Epub ahead of print]

44

22. Passweg JR, Rabusin M. Hematopoetic stem cell transplantation for immune

thrombocytopenia and other refractory autoimmune cytopenias. Autoimmunity. 2008 Oct 28:1. [Epub ahead of print] IF: 2.89

23. Martin Stern, Sandrine Meyer-Monard, Uwe Siegler, Jakob R Passweg. Natural Killer-Cell

based Treatment in Hematopoetic Stem Cell Transplantation in Allogeneic Stem Cell Transplantation. Clinical Research and Practice". Second Edition Humana Press 2008

24. Jakob R Passweg André Tichelli. Editorials and Perspectives: Immunosuppressive treatment

for aplastic anemia: are we hitting the ceiling? Hematologica 2009 eupb ahead of print IF: 5.98

25. Burjanadze M, Roosnek E, Passweg J, Huard B. [APRIL, the spring of plasmocytes.] Med Sci

(Paris). 2009 Jan;25(1):5-8. IF: 1.6 26. E. Roosnek, M. Burjanadze, P. Y. Dietrich, T. Matthes, J. Passweg, B. Huard. TUMORS

THAT LOOK FOR THEIR SPRINGTIME IN APRIL. (2008) submitted Crit Rev Oncol Hematol. 2009 Mar 13. [Epub ahead of print] IF: 4.63

27. Andrea Bacigalupo, Jakob Passweg. Diagnosis and Treatment of Acquired Aplastic Anemia

Hematol Oncol Clin North Am. 2009 Apr;23(2):159-70. IF 1.35 28. Lalive PH, Passweg JR, Kuntzer T. [Neuropathy associated with monoclonal gammopathy

(dysglobulinemia)] Rev Med Suisse. 2009 Apr 29;5(201):962-4, 966-7. 29. Benesch M, Urban C, Platzbecker U, Passweg J. Stem cell transplantation for patients with

Evans syndrome. Expert Rev Clin Immunol. 2009 May;5(3):341-8. 30. Passweg JR. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and

myelodysplastic syndromes.] Ther Umsch. 2010 May;67(5):251-5. German. 31. Tichelli A, Passweg JR. Editorial, Ther Umsch. 2010 May;67(5):211-2. 32. Tichelli A, Rovó A, Passweg J, Schwarze CP, Van Lint MT, Arat M, Socié G. Late

complications after hematopoietic stem cell transplantation. Expert Rev Hematol. 2009 Oct;2(5):583-601.

33. Les cellules souches du sang du cordon ombilical. Jakob R. Passweg, Yves Chalandon,

Thomas Lehmann, Vincent Kindler, André Tichelli; Paediatrica: 2010; 21; (5):52-55 34. CHRISTIAN TAVERNA, DANIEL DESALMAND, JÜRG GMÜR, MICHAEL GREGOR,

URS HESS, NICOLAS KETTERER, ERIKA LERCH, ULRICH MEY, THOMAS PABST, JAKOB PASSWEG, CHRISTOPH RENNER, JÉRÔME VÖGELI Lenalidomid bei vorbehandeltem multiplem Myelom. Leitfaden für die Therapie. SCHWEIZER ZEITSCHRIFT FÜR ONKOLOGIE 2010(3): 22-28

45

35. Passweg JR, Marsh JC. Aplastic Anemia: First-line Treatment by Immunosuppression and Sibling Marrow Transplantation. Hematology Am Soc Hematol Educ Program. 2010;2010:36-42.

36. Passweg J, Forrer F, Zimmermann F, Roser HW. Medizinische Folgen der Strahlenexposition,

Strahlenkrankheit und deren Behandlung. Swiss Medical Forum Nr. 30-31/2011 512-5] 37. D Heim, J R Passweg Fortbildung: Chronische Myeloische Leukämie. Info@Onkologie, 4-

2011: 11-14 38. Halter J,Passweg J, Häusermann P. Future trends in hematopoietic stem cell transplantation.

Curr Probl Dermatol. 2012;43:165-70. Epub 2012 Feb 17. PMID: 22377928 39. Daikeler T, Tichelli A, Passweg J. Complications of autologous hematopoietic stem cell

transplantation for patients with autoimmune diseases. Pediatr Res. 2012 Apr;71(4-2):439-444. doi: 10.1038/pr.2011.57. Epub 2012 Feb 8

40. Terszowski G, Passweg JR, Stern M. Natural killer cell immunity after transplantation. Swiss Med Wkly. 2012 Oct 17;142:0. doi: 10.4414/smw.2012.13700. PMID: 23135787 [PubMed - in process]

41. Passweg J, Halter J, Bucher C, Gerull S, Heim D, Rovó A, Buser A, Stern M, Tichelli A. Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner. Swiss Med Wkly. 2012 Oct 15;142:0. doi: 10.4414/smw.2012.13696. PMID: 23135685 [PubMed - as supplied by publisher]

42. Aljurf M, Al-Zahrani H, Van Lint MT, Passweg JR. Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor. Bone Marrow Transplant. 2012 Nov 19. doi: 10.1038/bmt.2012.223. [Epub ahead of print] PMID: 23165494

43. Passweg JR, Aljurf M. Treatment and hematopoietic SCT in aplastic anemia. Bone Marrow Transplant. 2012 Nov 19. doi: 10.1038/bmt.2012.229. [Epub ahead of print] No abstract available. PMID: 2316549

44. Bucher CM, Passweg JR. Towards rational graft-versus-host disease prophylaxis. Haematologica. 2012 Dec;97(12):1779-80. doi: 10.3324/haematol.2012.080226. PMID: 23204477

45. JR Passweg, JCW Marsh: Optimizing hematopoetic stem cell transplantation for bone marrow failure syndromes. Hematology Education: the education program for the annual congress of the European Hematology Association 2013;7:109-114

46. JR Passweg, H Baldomero. Overview: transplant data and increasing numbers of long term survivors: Blood and Marrow Transplantation Long-Term Management Ed B Savani, Wiley Blackwell 2013

47. A Tichelli, JP Halter, JR Passweg, A Rovo: Long-term transplant clinic setup Blood and Marrow Transplantation Long-Term Management Ed B Savani, Wiley Blackwell 2013

46

48. Medinger M, Passweg J. Role of tumour angiogenesis in haematological malignancies. Swiss Med Wkly. 2014 Nov 6;14: eCollection 2014.

49. Tichelli A, Passweg JR. Matched sibling donor hematopoietic stem cell transplant in patients

with acquired aplastic anemia. Curr Drug Targets. 2014 Dec 24. [Epub ahead of print] PMID: 25537652

50. Medinger M, Passweg J. Angiogenesis in myeloproliferative neoplasms, new markers and future directions. Memo. 2014;7:206-210. Epub 2014 May 22. PMID: 25544863

Letters to the editor; Drug Letters, and Non-Peer Reviewed Contributions

1. J Passweg. Synopsis: Tryptophan. pharma-kritik 1985; 7:33 2. J Passweg. Synopsis: "Fumarsäuretherapie" der Psoriasis. pharma-kritik: 1985; 7:73 3. J Passweg. Uebersicht: Schlafmittel: pharma-kritik 1985; 7:85 4. J Passweg. Synopsis: Betaxolol: pharma-kritik: 1986; 8:1 5. J Passweg. Synopsis: Ein transdermales Oestradiol-präparat: 1986; 8:17 6. J Passweg. Uebersicht: orale Venenpharmaka: pharma-kritik: 1986; 8:37 7. J Passweg. Synopsis: Tocainid: pharma-kritik: 1986; 8:55 8. J Passweg. Uebersicht: Medikamentöse Behandlung der Prostatahyperplasie: pharma-kritik

1986; 8:65 9. J Passweg. Synopsis: Josamycin: pharma-kritik: 1987; 9:7 10. J Passweg. Uebersicht: Behandlung der orthostatischen Hypotonie: pharma-kritik: 1987;

9:73 11. J Passweg. Synopsis: Medikamente als Ursache orthostatischer Hypotonie: pharma-kritik:

1987; 9:78 12. J Passweg. Uebersicht: Magnesium: pharma-kritik 1991;13:53 13. J Passweg. Uebersicht: Behandlung des Herpes simplex: pharma-kritik: 1991;13:85 14. UP. Masche und J. Passweg. Synopsis: Imatinib pharma-kritik 2001; 23:29

15. J Passweg. Antithymocyte Globulin and Cyclosporine to treat patients with

myelodysplastic Syndrome. A randomized trial comparing ATG+CSA with best suportive care. Protocol SAKK 33/99. Schweizer Krebsbulletin, 1999, 19:63-64

16. Vijay Reddy, Shahab Khan, John R. Wingard;, J. Marsh, H. Schrezenmeier, P. Marin, O.

Ilhan, S. McCann, G. Socie, A. Tichelli, J. Passweg, J. Hows, A. Raghavachar, A. Locascuilli, and A. Bacigalupo Treatment Results in Aplastic Anemia. Trials Need To Be Analyzed Separately for Pediatric and Adult Populations Blood 1999 94: 1833-1834

17. A Gratwohl, J Passweg. Allogene-”Mini”-Transplantation. Schweizer Krebsbulletin, 2000

20: (3) 128-129

18. J. Passweg, Aerzteseminare Karlsruhe, 30.11.2001 Neurologie Intensivkurs; Hämopoetische Stammzelltransplantation bei schweren Autoimmunerkrankungen, pp122

19. M Trendelenburg, M Gregor, J Passweg, A Tichelli, A Tyndall, A Gratwohl. 'Altered

immunity syndrome', a distinct entity in long-term bone marrow transplantation survivors? Bone Marrow Transplantation 2001, 28:1175-6

47

20. Gratwohl A, Passweg J, Kühne T, Tyndall A, Holzgreve W, Skoda R, Marbet G, Tichelli A. Hämatopoietische Stammzelltransplantation Swiss Medical Forum 2002:597-606

21. A Lohri, L Jost, Ch Landmann, J Passweg, R Herrmann. Die malignen Lymphome (3.

Teil). Swiss Med Forum 2002:827-834

22. Passweg J, Gratwohl A. Reply to the letter by C Craddock and A P Grigg. Bone Marrow Transplant. 2003 Jun;31(12):1179

23. Armin Droll, Franziska Kunz, Jakob R. Passweg, Marc Michot. Fatal Mucor infection

leading to multiorgan failure in a patient with a myelodysplatic syndrome. Images in Haematology Br. J. Haematol 2004 126, 441

24. Bekassy AN, Locasciulli A, Marsh JC, Socie G, Fuehrer M, Passweg J.

Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling. Pediatr Blood Cancer. 2005 Sep;45(3):359-60

25. Passweg JR. La SAKK vue par le groupe de projet “leucémie”. Schweizerisches

Krebsbulletin 2005; 25:52

26. Passweg JR 100 Jahre Krebsliga – auf ins neue Jahrhundert Schweizerisches Krebsbulletin 2010; 30:2:99-100

27. Passweg JR Lösungsvorschläge zur Stärkung der akademischen klinischen Forschung

Schweizerisches Krebsbulletin 2010; 30:3:216-7

28. Dr. Peter Brauchli, Dr. Claudia Weiss, Pascale Wenger, Prof. Beat Thürlimann, Prof. Thomas Cerny, Prof. Rolf Stahel, PD Dr. Nicolas von der Weid, Prof. Jakob Passweg, Prof. Richard Herrrmann. Welche gesetzliche Regelung braucht die patientenorientierte Forschung? Schweizerische Ärztezeitung | Bulletin des médecins suisses | Bollettino dei medici svizzeri | 2011;92: 4

29. European Blood and Marrow Transplant Group, Severe Aplastic Anaemia Working Party.

Collaborators (11) Dufour C, Bacigalupo A, Oneto R, Socie G, Tichelli A, Passweg JR, Risitano AM, Schrezenmeier H, Locasciulli A, Aljurf M, Marsh JC. Rabbit ATG for aplastic anaemia treatment: a backward step? Lancet. 2011 Nov 26;378(9806):1831-3. Epub 2011 Jul 5. PMID 21737135

30. Jakob R. Passweg, Dominik Heim, Lukas Graf, Dimitrios A. Tsakiris. Medizinische

Schlaglichter: Hämatologie: neue Therapieindikationen für neue Substanzen. Swiss Medical Forum 2011 2011;11(51–52):967–968

31. Jakob R Passweg. Unrelated donor transplantation for aplastic anemia. Leukemia

Supplements (2012) 1, S36

32. Jakob R Passweg, André Tichelli. Myelodysplastisches Syndrom. Info@Onkologie 2012:3:5-7

48

33. Nathan Cantoni, Jakob R Passweg, Thomas Lehmann. BCR-ABL1-negative Myeloproliferative Neoplasie. Info@Onkologie 2012:3:8-11

34. Nathan Cantoni, Thomas Lehmann, Jakob R Passweg. Myeloproliferative Neoplasien,

Klinische Relevanz neuer Mutationen. Info@Onkologie 2012:313-15

35. Bucher CM, Passweg J. Reply to: Towards a rational graft-versus-host disease prophylaxis: rituximab should not be forgotten.Haematologica. 2013 Apr;98(4):e48-48. doi: 10.3324/haematol.2013.083584. No abstract available. PMID: 23543156

36. Cerny T, Passweg J, Noseda G Swiss Medical Board – cui bono? Schweizerische

Aerztezeitung 6/2014 1726-8

37. Wójtowicz A, Doco Lecompte T, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study STCS. Achermann R, Aubert JD, Baumann P, Beldi G, Benden C, Berger C, Binet I, Bochud PY, Boely E, Bucher H, Bühler L, Carell T, Catana E, Chalandon Y, de Geest S, de Rougemont O, Dickenmann M, Duchosal M, Fehr T, Ferrari-Lacraz S, Garzoni C, Gasche Y, GascheSoccal P, Giostra E, Golshayan D, Good D, Hadaya K, Hess C, Hillinger S, Hirsch HH, Hofbauer G, Huynh-Do U, Immer F, Klaghofer R, Koller M, Kuntzen T, Laesser B, Lehmann R, Lovis C, Manuel O, Marti HP, Martin PY, Meylan P, Mohacsi P, Morard I, Morel P, Mueller U, Mueller NJ, Mueller-McKenna H, Müller T, Müllhaupt B, Nadal D, Nair G, Pascual M, Passweg J, Ziegler CP, Rick J, Roosnek E, Rosselet A, Rothlin S, Ruschitzka F, Schanz U, Schaub S, Seiler C, Semmo N, Stampf S, Steiger J, Toso C, Tsinalis D, Van Delden C, Venetz JP, Villard J, Wick M, Wilhelm M, Yerly P. Reply to Cunha, et al. Clin Infect Dis. 2015 Aug 10. pii: civ681. [Epub ahead of print]

49